US20120041548A1 - Apparatus for atrioventricular valve repair - Google Patents
Apparatus for atrioventricular valve repair Download PDFInfo
- Publication number
- US20120041548A1 US20120041548A1 US13/280,112 US201113280112A US2012041548A1 US 20120041548 A1 US20120041548 A1 US 20120041548A1 US 201113280112 A US201113280112 A US 201113280112A US 2012041548 A1 US2012041548 A1 US 2012041548A1
- Authority
- US
- United States
- Prior art keywords
- fastening mechanism
- valve
- leaflet
- accordance
- heart
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/04—Surgical instruments, devices or methods, e.g. tourniquets for suturing wounds; Holders or packages for needles or suture materials
- A61B17/0401—Suture anchors, buttons or pledgets, i.e. means for attaching sutures to bone, cartilage or soft tissue; Instruments for applying or removing suture anchors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/24—Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body
- A61F2/2442—Annuloplasty rings or inserts for correcting the valve shape; Implants for improving the function of a native heart valve
- A61F2/2454—Means for preventing inversion of the valve leaflets, e.g. chordae tendineae prostheses
- A61F2/2457—Chordae tendineae prostheses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/08—Wound clamps or clips, i.e. not or only partly penetrating the tissue ; Devices for bringing together the edges of a wound
- A61B17/085—Wound clamps or clips, i.e. not or only partly penetrating the tissue ; Devices for bringing together the edges of a wound with adhesive layer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B2017/00743—Type of operation; Specification of treatment sites
- A61B2017/00778—Operations on blood vessels
- A61B2017/00783—Valvuloplasty
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B2017/00831—Material properties
- A61B2017/00867—Material properties shape memory effect
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/04—Surgical instruments, devices or methods, e.g. tourniquets for suturing wounds; Holders or packages for needles or suture materials
- A61B17/0401—Suture anchors, buttons or pledgets, i.e. means for attaching sutures to bone, cartilage or soft tissue; Instruments for applying or removing suture anchors
- A61B2017/0412—Suture anchors, buttons or pledgets, i.e. means for attaching sutures to bone, cartilage or soft tissue; Instruments for applying or removing suture anchors having anchoring barbs or pins extending outwardly from suture anchor body
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/04—Surgical instruments, devices or methods, e.g. tourniquets for suturing wounds; Holders or packages for needles or suture materials
- A61B17/0401—Suture anchors, buttons or pledgets, i.e. means for attaching sutures to bone, cartilage or soft tissue; Instruments for applying or removing suture anchors
- A61B2017/0427—Suture anchors, buttons or pledgets, i.e. means for attaching sutures to bone, cartilage or soft tissue; Instruments for applying or removing suture anchors having anchoring barbs or pins extending outwardly from the anchor body
- A61B2017/0437—Suture anchors, buttons or pledgets, i.e. means for attaching sutures to bone, cartilage or soft tissue; Instruments for applying or removing suture anchors having anchoring barbs or pins extending outwardly from the anchor body the barbs being resilient or spring-like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/04—Surgical instruments, devices or methods, e.g. tourniquets for suturing wounds; Holders or packages for needles or suture materials
- A61B17/0401—Suture anchors, buttons or pledgets, i.e. means for attaching sutures to bone, cartilage or soft tissue; Instruments for applying or removing suture anchors
- A61B2017/044—Suture anchors, buttons or pledgets, i.e. means for attaching sutures to bone, cartilage or soft tissue; Instruments for applying or removing suture anchors with a threaded shaft, e.g. screws
- A61B2017/0443—Suture anchors, buttons or pledgets, i.e. means for attaching sutures to bone, cartilage or soft tissue; Instruments for applying or removing suture anchors with a threaded shaft, e.g. screws the shaft being resilient and having a coiled or helical shape in the released state
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/04—Surgical instruments, devices or methods, e.g. tourniquets for suturing wounds; Holders or packages for needles or suture materials
- A61B17/0401—Suture anchors, buttons or pledgets, i.e. means for attaching sutures to bone, cartilage or soft tissue; Instruments for applying or removing suture anchors
- A61B2017/0464—Suture anchors, buttons or pledgets, i.e. means for attaching sutures to bone, cartilage or soft tissue; Instruments for applying or removing suture anchors for soft tissue
Definitions
- This invention relates generally to medical methods and apparatus, and more particularly, to methods and apparatus for the endovascular or minimally invasive surgical repair of atrioventricular valves of the heart, including the mitral valve and the tricuspid valve.
- the heart includes four valves that direct blood through the two sides of the heart.
- the mitral valve lies between the left atrium and the left ventricle and controls the flow of blood into the left side of the heart.
- the valve includes two leaflets, an anterior leaflet and a posterior leaflet, that close during systole.
- the leaflets are passive in that they open and close in response to pressure induced to the leaflets by the pumping of the heart. More specifically, during a normal cycle of heart contraction (systole), the mitral valve functions as a check valve to prevent the flow of oxygenated blood back into the left atrium. In this manner, oxygenated blood is pumped into the aorta through the aortic valve.
- mitral valve regurgitation in which the mitral valve leaflets become unable to close properly during systole, thus enabling leakage to flow through the mitral valve during systole. Over time, regurgitation of the mitral valve can adversely affect cardiac function and may compromise a patient's quality of life and/or life-span.
- Mitral valve regurgitation can result from a number of different mechanical defects in the mitral valve.
- the valve leaflets, the valve chordae which connect the leaflets to the papillary muscles, or the papillary muscles themselves may become damaged or otherwise dysfunctional.
- the valve annulus may become damaged or weakened and may limit the ability of the mitral valve to close adequately during systole.
- Percutaneously treatments are less invasive than the treatments mentioned above, but such treatments may be less effective and more difficult to effect repair because of the limited amount of space in and around the mitral valve in which to maneuver a repair device or devices.
- U.S. Pat. No. 6,875,224 to Grimes describes a percutaneous mitral valve repair method in which the opposed leaflets are each immobilized to enable the two leaflets to be fastened together.
- U.S. Pat. No. 6,6290,534 to St. Goar et al. describes a plurality of embodiments for use in endovascular repair of cardiac valves in which, in each embodiment, both leaflets are grasped and held firmly in position prior to permanent treatment.
- grasping both leaflets while the patient's heart is beating may be a time-consuming and laborious task that demands a coordinated effort on the part of the surgical team.
- to facilitate grasping both leaflets percutaneously may require that the patient's heart be temporarily stopped or slowed by drugs or other techniques. Slowing and/or stopping the patient's heart during surgery may increase the risks to the patient.
- a method of repairing an atrioventricular valve in a patient comprises accessing the patient's atrioventricular valve percutaneously, securing a fastening mechanism to a valve leaflet, and coupling the valve leaflet, while the patient's heart remains beating, to at least one of a ventricular wall adjacent the atrioventricular valve, a papillary muscle, at least one valve chordae, and a valve annulus to facilitate reducing leakage through the valve.
- a method of repairing a mitral valve in the heart of a patient comprises accessing the patient's mitral valve percutaneously, securing a first end of a fastening mechanism to a valve leaflet of the mitral valve, and coupling a second end of the fastening mechanism to a cardiac structure other than a mitral valve leaflet to facilitate reducing leakage through the patient's mitral valve during ventricular systole.
- a method of enhancing operation of a patient's heart valve comprises inserting a guide catheter along the venous system of the patient to approach the mitral valve, guiding a fastening mechanism towards one of a mitral valve and a tricuspid valve within the patient's heart, and securing a first end of the fastening mechanism to one of the mitral valve and the tricuspid valve using one of fusing, gluing, stapling, clipping, riveting, anchoring, and suturing.
- the method also comprises securing a second end of the fastening mechanism to a cardiac structure other than a valve leaflet to facilitate enhancing operation of the valve during ventricular systole.
- a medical kit for use in repairing a mitral valve includes a guide catheter and a fastening mechanism.
- the guide catheter is configured for insertion along the venous system of the patient to approach the mitral valve.
- the fastening mechanism is positionable percutaneously within the patient using the guide catheter.
- the fastening mechanism includes a first end and an opposite second end. The first end is configured to couple to the mitral valve using one of fusing, gluing, stapling, clipping, riveting, anchoring, and suturing.
- the second end is configured to only couple to a cardiac structure other than a valve leaflet to facilitate enhancing operation of the valve during ventricular systole.
- FIG. 1 is a cross-sectional view of the left and right ventricles of a human heart in diastole;
- FIG. 2 is an another cross-sectional view of the heart shown in FIG. 1 during systole;
- FIG. 3 is an exemplary schematic illustration of a fastening mechanism that may be used to facilitate repair of a cardiac valve within the heart shown in FIGS. 1 and 2 ;
- FIG. 4 is an enlarged view of a portion of the fastening mechanism shown in FIG. 1 and coupled to a papillary muscle in the heart shown in FIGS. 1 and 2 ;
- FIG. 5 is a schematic view of an alternative embodiment of a portion of a fastening mechanism that may be used to facilitate repair of a cardiac valve within the heart shown in FIGS. 1 and 2 ;
- FIG. 6 is a schematic view of an another alternative embodiment of a portion of a fastening mechanism that may be used to facilitate repair of a cardiac valve within the heart shown in FIGS. 1 and 2 ;
- FIG. 7 is a schematic view of a further alternative embodiment of a portion of a fastening mechanism that may be used to facilitate repair of a cardiac valve within the heart shown in FIGS. 1 and 2 ;
- FIG. 1 is a cross-sectional view of the left and right ventricles 10 and 12 , respectively, of a human heart 14 during diastole. Ventricles 10 and 12 are separated by an interatrial septum 15 .
- FIG. 2 is a cross-sectional view of heart 14 during systole.
- the present invention provides methods and apparatus for the endovascular repair of cardiac valves, particularly atrioventricular valves 16 , which inhibit back-flow of blood from a heart ventricle during contraction (systole).
- the present invention may be used in repairing, but is not limited to repairing, mitral valves 20 .
- the term “endovascular,” refers to procedure(s) of the present invention that are performed with interventional tools and supporting catheters and other equipment introduced to the heart chambers from the patient's arterial or venous vasculature remote from the heart.
- the interventional tools and other equipment may be introduced percutaneously, i.e., through an access sheath, or may be introduced via a surgical cut down, and then advanced from the remote access site through the vasculature until they reach heart 14 .
- the methods and apparatus described herein generally do not require penetrations made directly through an exterior heart muscle, i.e., myocardium, although there may be some instances where penetrations will be made interior to the heart, e.g., through the interatrial septum to provide for a desired access route.
- the methods and apparatus described herein are not limited to use with percutaneous and intravascular techniques, but rather the present invention may be used with open surgical procedures as well.
- the atrioventricular valves 16 are each located at a junction of the atria and their respective ventricles.
- the atrioventricular valve 16 extending between the right atrium 30 and the right ventricle 12 has three valve leaflets (cusps) and is referred to as the tricuspid or right atrioventricular valve 31 .
- the atrioventricular valve 16 between the left atrium 32 and the left ventricle 10 is a bicuspid valve having only two leaflets or cusps 34 and is generally referred to as the mitral valve 20 .
- valve leaflets 34 open during diastole when the heart atria fill with blood, allowing the blood to pass into the ventricle.
- the valve leaflets 34 are pushed together such that the free edges 36 of the leaflets 34 are closed against each other along a line of coaptation to prevent the back-flow of blood into the atria.
- Back flow of blood or “regurgitation” through the mitral valve 20 is facilitated to be prevented when the leaflets 34 are closed, such that the mitral valve 20 functions as a “check valve” which prevents back-flow when pressure in the left ventricle 10 is higher than that in the left atrium 32 .
- the mitral valve leaflets 34 are attached to the surrounding heart structure along an annular region referred to as the valve annulus 40 .
- the free edges 36 of the leaflets 34 are secured to the lower portions of the left ventricle 10 through tendon-like tissue structures, known as chordae tendineae or chordae 42 .
- the chordae 42 are attached to the papillary muscles 44 which extend upwardly from the lower portions of the left ventricle and interventricular septum 46 .
- a number of structural defects in the heart can cause mitral valve regurgitation.
- ruptured chordae 42 may cause a valve leaflet 34 to prolapse if inadequate tension is induced to the leaflet 34 through the remaining unruptured chordae 42 .
- regurgitation may also occur in patients suffering from cardiomyopathy, wherein the heart 14 is dilated and the increased size prevents the valve leaflet edges 36 from contacting each other properly, or in patients who have suffered ischemic heart disease wherein the functioning of the papillary muscles 44 may be impaired.
- the free edges 36 of the anterior and posterior leaflets 34 do not contact sufficiently along the line of coaptation, but rather leakage may occur through a gap defined between the leaflets 34 .
- FIG. 3 is an exemplary schematic illustration of a fastening mechanism 50 that may be used to facilitate repair of an atrioventricular valve 16 within heart 14 (shown in FIGS. 1 and 2 ).
- FIG. 4 is an enlarged view of a portion of the fastening mechanism shown in FIG. 3 and coupled to a papillary muscle 44 .
- Fastening mechanism 50 includes a first attachment end 60 and a second attachment end 62 .
- first attachment end 60 includes a generally deformable clip portion 64 that is sized and shaped to couple to a free edge 36 (shown in FIGS. 1 and 2 ) of a leaflet 34 (shown in FIGS. 1 and 2 ).
- first attachment end 60 is coupled to leaflet 34 without using clip portion 64 .
- clip portion 64 is variably selected based on the leaflet 34 being repaired.
- portion 64 is pinched or crimped against a leaflet free edge 36 to facilitate repair of the valve as described in more detail below.
- fastening mechanism 50 is coupled to valve 16 such that an outer surface of leaflet free edge 36 is grasped without mechanism 50 penetrating the leaflet tissue.
- the leaflet free edge 36 is crimped between opposing sides 66 and 68 of portion 64 .
- portion 64 is coupled to a free edge 36 using any suitable means that enables portion 64 to remain coupled to leaflet free edge 36 , such as, but not limited to, with gluing, stapling, suturing, fusing, riveting, external clips, or any combination thereof
- first attachment end 60 may be secured to leaflet 34 through atraumatic partial, or full penetration, or piercing of leaflet 34 .
- first attachment end 60 and/or portion 64 may include attachment prongs that extend from clip portion 64 and that are configured to pinch, partially penetrate, or pierce the leaflet 34 .
- first attachment end 60 may be inserted from a first side of the leaflet 34 , through leaflet 34 , and outward from an opposite second side of the leaflet 34 . In such an embodiment, in use first attachment end 60 is coupled to, and secured against the second side of the leaflet.
- first attachment end is inserted only partially through the leaflet 34 , and thus is secured to leaflet tissue intermediate the first and second sides of the leaflet.
- first attachment end 60 is attached to leaflet 34 using any suitable means that will enable fastening mechanism 50 to function as described herein, such as, but not limited to, an adhesive process, a riveting process, a suturing process, a stapling process, or any combination thereof.
- a threaded locking member or any other suitable mechanical coupling may be used to secure first attachment end 60 to the leaflet.
- attachment end 60 may be fused directly to the leaflet 34 using a known fusion process in which laser, RF, microwave or ultrasonic energy, for example, is applied at specified coaptation points.
- clip portion 64 is fabricated from a formable material that is coated in a protective cloth-like material.
- Clip portion 64 may be fabricated from any suitable biocompatible material that enables fastening mechanism 50 to function as described herein, such as, but not limited to, titanium alloys, platinum alloys, stainless steel, or any combination thereof.
- clip portion 64 is coated with a fabric material such as, but not limited to, a DACRON® material, a TEFLON® material, a GORE-TEX®, or any material or combination thereof that enables clip portion 64 to function as described herein.
- clip portion 64 is covered by a material that encourages tissue in-growth.
- a tensioning member 70 extends from clip portion 64 to second attachment end 62 .
- the overall size, shape, and material used in member 70 is variably selected depending on the application.
- member 70 is fabricated from a mesh material.
- the relative location of member 70 with respect to clip portion 64 is variably selected based on the amount of tension to be induced, the desired locations for the tension to be induced, and based on the leaflet 34 being repaired.
- tensioning member 70 includes an attachment pad 74 .
- fastening mechanism 50 includes more than one tensioning member 70 .
- fastening mechanism 50 may include a single tensioning member 70 that includes a forked or bifurcated end that includes two pads 74 .
- fastening tensioning member 70 does not include pad 74 .
- fastening mechanism 50 includes at least one tensioning member that is formed with a looped end that is sized to circumscribe the cardiac structure to which it is attached, and is cinchable to facilitate securing fastening mechanism 50 to the papillary muscle 44 .
- Tensioning member 70 facilitates inducing tension to the leaflet 34 being repaired, and pad 74 facilitates distributing loading across the papillary muscle 44 .
- pad 74 is sized for placement along an external surface of papillary muscle 44 when fastening mechanism 50 is coupled to the papillary muscle 44 .
- tensioning member 70 and pad 74 are formed integrally together.
- pad 74 may be securely coupled to member 70 using any of a plurality of known coupling means.
- member 70 is coupled to papillary muscle 44 using a fastener (not shown) that is inserted at least partially through papillary muscle 44 .
- the fastener has a tack-like configuration.
- the fastener is mechanically coupled to the papillary muscle 44 using, for example, a suitable threaded coupling.
- at least one of a pair of interlocking fasteners is inserted through a pad 74 prior to insertion through the papillary muscle 44 and prior to the two fasteners being interlocked.
- pad 74 is coupled in position against the papillary muscle 44 by a cinch-type fastener that circumscribes the papillary muscle 44 when securely cinched.
- pad 74 is coupled directly to the papillary muscle 44 using any suitable means that will enable fastening mechanism 50 to function as described herein, such as, but not limited to, an adhesive process, a riveting process, a suturing process, a coil or corkscrew device, a stapling process, external clips, or any combination thereof.
- a threaded locking member and a self-locking or spin-lock ratcheting fastener may be used to secure member 70 to the papillary muscle 44 .
- pad 74 , and/or tensioning member 70 is coupled to the papillary muscle 44 using a flat ribbon that has been heat-set in the shape of double loops.
- Pad 74 and member 70 may be fabricated from any material that enables pad 74 and member 70 to function as described herein.
- pad 74 and member 70 may be fabricated from, but are not limited to being fabricated from, a DACRON® material, a TEFLON® material, a GORE-TEX®, or any material or combination.
- pad 74 and member 70 may be fabricated from, but are not limited to being fabricated from a superelastic material or a shaped memory alloy (SMA) material, such as, but not limited, to Nitinol®, stainless steel, plastic, or any of several known shaped memory alloys (SMA) that have properties that develop a shaped memory effect (SME).
- SMA shaped memory alloy
- pad 74 is fabricated from a material that encourages tissue in-growth.
- first attachment end 60 is coupled securely to mitral valve 20 and second attachment end 62 is coupled to a cardiac structure, such as the papillary muscle 44 .
- second attachment end 62 may be coupled to any cardiac structure other than a mitral valve leaflet 34 such as, but not limited to, a ventricular wall 46 adjacent the atrioventricular valve 30 , a valve chordae 42 , either intact or ruptured, a valve annulus 36 , an interatrial septum 15 or any combination thereof.
- second attachment end 62 is coupled to the papillary muscle 44 .
- member 70 are variably selected to facilitate inducing a desired tension to leaflet 34 and to facilitate improving the ability of the atrioventricular valve 16 to close against the elevated pressures within the ventricle during systole. More specifically, member 70 is variably selected to facilitate modifying operation of the leaflet 34 such that the free ends 36 of the opposed leaflets 34 again contact each other during systole along the line of coaptation to prevent the back-flow or regurgitation of blood through the mitral valve 20 into the atria.
- FIG. 5 is a schematic view of an alternative embodiment of a portion of a fastening mechanism 100 that may be used to facilitate repair of a cardiac valve 16 (shown in FIGS. 1 and 2 ).
- Fastening mechanism 100 is substantially similar to fastening mechanism 50 (shown in FIGS. 3 and 4 ) and, components of fastening mechanism 100 that are identical to components of fastening mechanism 50 are identified in FIG. 5 using the same reference numerals used in FIGS. 3 and 4 .
- fastening mechanism 100 includes first attachment end 60 , second attachment end 62 (shown in FIGS. 3 and 4 ), and at least one tensioning member 110 extending therebetween.
- tensioning member 110 includes an anchor member 112 . It should be noted that although attachment end 60 is illustrated, the anchor member 112 may also be included at attachment end 62 and/or end 60 , or at any suitable location between ends 60 and 62 depending on the application.
- Tensioning member 110 is substantially similar to tensioning member 70 and as such, facilitates inducing tension to the leaflet 34 (shown in FIGS. 1 and 2 ) being repaired.
- tensioning member 110 and anchor member 112 are formed integrally together.
- anchor member 112 may be securely coupled to tensioning member 110 using any of a plurality of known coupling means.
- member 110 is coupled to leaflet 34 using anchor member 112 , or any other cardiac structure other than a mitral valve leaflet 34 , such as, but not limited to, a ventricular wall 46 (shown in FIGS. 1 and 2 ) adjacent the atrioventricular valve 30 (shown in FIGS. 1 and 2 ), a valve chordae 42 (shown in FIGS.
- valve annulus 36 shown in FIGS. 1 and 2
- interatrial septum 15 shown in FIGS. 1 and 2
- papillary muscle 44 shown in FIGS. 1 , 2 , and 4
- anchor member 112 has a distal end 114 that is pointed and is self-piercing that facilitates transmural attachment to a ventricular wall.
- the anchor member distal end 114 may be fabricated of any material having sufficient rigidity to pierce, and/or at least partially penetrate, through a portion of the cardiac component to which it is intended to be attached.
- the distal end 114 may be fabricated from, but is not limited to being fabricated from, stainless steel, titanium, various shaped memory or superelastic materials, metal alloys, various polymers, and combinations thereof.
- the geometries, tip sharpness, and dimensions of anchor member 112 are variably selected to ensure a desired amount of piercing, if any, occurs.
- the anchor member distal end 114 does not actually pierce the cardiac structure, but rather is positioned in a desired position by a surgical instrument, such as, but not limited to a piercing catheter or a needle.
- anchor member 112 includes a plurality of anchoring arms 120 that are biased outwardly from tensioning member 110 .
- anchor member 112 may include, but is not limited to including, a plurality of penetrating and/or non-penetrating petals, wings, propellers, coils, arms, ribbons, tubes, loops, grappling hooks, barbs, or clips, that are extend outwardly from tensioning member 110 to enable fastening mechanism 100 to function as described herein.
- anchor member 112 may include expandable arms that expand outwardly from a compressed state.
- the arms 120 function similarly to an umbrella and include a pleated, supported material member that is biased outwardly, as described herein.
- the cross-sectional shape of arms 120 is illustrated as exemplary only. Rather, anchor member 112 , arms 120 , and tensioning member 110 may be fabricated with any cross-sectional shape that enables fastening mechanism 100 to function as described herein.
- arms 120 are biased outwardly such as is possible using pre-shaped, resilient metallic rods, for example.
- the arms 120 may be fabricated from any suitable material and in any suitable manner that enables arms 120 to function as described herein.
- arms 120 may be fabricated from, but are not limited to being fabricated from Nitinol®, stainless steel, plastic, superelastic alloys, polymers, or any of several known shaped memory alloys (SMA) that have properties that develop a shaped memory effect (SME).
- arms 120 may be fabricated from, but are not limited to being fabricated from, a DACRON® material, a TEFLON® material, a GORE-TEX®, or any material or combination.
- arms 120 are fabricated from a material that encourages tissue in-growth.
- arms 120 are advanced through the penetration or opening and are displaced outwardly. More specifically, as tensioning member 100 is withdrawn or retracted from the opening in an opposite direction to that of insertion within the opening, because arms 120 are biased outwardly from tensioning member 100 . More specifically, the biasing of the arms 120 causes the arms 120 to contact the surface of the cardiac component radially outward from the opening, such that the arms 120 are not retractable through the opening as tensioning member 100 is withdrawn from the opening. Rather, as tensioning member 100 is withdrawn from the opening, anchor member 112 is secured against a tissue surface of the cardiac component.
- FIG. 6 is a schematic view of an alternative embodiment of a portion of a fastening mechanism 150 that may be used to facilitate repair of a cardiac valve 16 (shown in FIGS. 1 and 2 ).
- Fastening mechanism 150 is substantially similar to fastening mechanisms 50 and 100 (shown in FIGS. 3 and 4 , and 5 , respectively) and, components of fastening mechanism 150 that are identical to components of fastening mechanism 50 and 100 are identified in FIG. 6 using the same reference numerals used in FIGS. 3-5 . Accordingly, fastening mechanism 150 includes first attachment end 60 (shown in FIGS. 3-5 ), second attachment end 62 (shown in FIGS. 3 and 4 ), and at least one tensioning member 152 extending therebetween.
- tensioning member 152 includes an anchor member 156 . It should be noted that although attachment end 62 is illustrated, the anchor member 156 may also be included at attachment end 60 and/or end 62 , or at any suitable location between ends 60 and 62 depending on the application.
- Tensioning member 152 is substantially similar to tensioning member 70 , and/or tensioning member 110 , and as such, facilitates inducing tension to the leaflet 34 (shown in FIGS. 1 and 2 ) being repaired.
- tensioning member 152 and anchor member 156 are formed integrally together.
- anchor member 156 may be securely coupled to tensioning member 152 using any of a plurality of known coupling means.
- member 152 is coupled to leaflet 34 using anchor member 156 , or any other cardiac structure other than a mitral valve leaflet 34 , such as, but not limited to, a ventricular wall 46 (shown in FIGS. 1 and 2 ) adjacent the atrioventricular valve 30 (shown in FIGS.
- valve chordae 42 shown in FIGS. 1 and 2
- valve annulus 36 shown in FIGS. 1 and 2
- interatrial septum 15 shown in FIGS. 1 and 2
- papillary muscle 44 shown in FIGS. 1 , 2 , and 4
- anchor member 156 is formed with a cork-screw or coil configuration and has a distal end 160 that is pointed and is self-piercing. Accordingly, the anchor member 156 may be fabricated of any material having sufficient rigidity to pierce, and/or at least partially penetrate, through a portion of the cardiac component to which it is intended to be attached.
- the distal end 156 may be fabricated from, but is not limited to being fabricated from, stainless steel, titanium, various shape memory or superelastic materials, metal alloys, various polymers, and combinations thereof.
- the anchor member 156 is not self-tapping, but rather is threadably coupled within a starter hole formed a surgical instrument, such as, but not limited to a piercing catheter or a needle.
- anchor member 156 may be formed from a shape memory wire that is annealed or heat-set in a straight configuration and then coiled. In such an embodiment, anchor member 156 may be processed to have different properties by varying the diameter and tension therein along its length. For example, when anchor member 156 is heated to a pre-determined temperature, such as with RF energy, a designated portion of anchor member 156 will become a randomly oriented mass of material having self-locking struts to prevent disentanglement. When the anchor member 156 is heated to a different pre-determined temperature, a full entanglement of occurs such that anchor member 156 is compressed together.
- a pre-determined temperature such as with RF energy
- anchor member 156 includes a plurality of tines or arms that are biased outwardly from member 156 , and more particularly from tip 160 .
- the arms facilitate securing the anchor member 156 in position within the cardiac structure to which it is embedded.
- anchor member 156 may include expandable arms that expand outwardly from a compressed state.
- anchor member 156 may include other self-locking struts that facilitate preventing member 156 from backing out of the cardiac structure to which it is threadalby coupled.
- the cross-sectional shape of anchor member 156 is illustrated as exemplary only.
- anchor member 156 and tensioning member 152 may be fabricated with any cross-sectional shape, dimensions, or material that enables fastening mechanism 150 to function as described herein.
- anchor member 156 may be formed with, but is not limited to being formed with, a self-tapping screw configuration, a mesh configuration, or with a helical configuration.
- anchor member 156 is formed with a coiled configuration having a helical filament that includes a secondary helical structure that includes, for example, a plurality of loops.
- anchor member 156 may include an inner element fabricated from a shaped memory material and an outer element that is substantially concentrically aligned with respect to the inner element, and is fabricated from a second material, such as a radiopaque material or a heat-activated material.
- the coil may be fabricated with a stacked coil configuration in which no space is defined between adjacent windings of the coil, but rather, the coil assumes a coil configuration when heated to a pre-determined temperature as it is deployed.
- FIG. 7 is a schematic view of an alternative embodiment of a portion of a tensioning member 200 that may be used to facilitate repair of a cardiac valve 16 (shown in FIGS. 1 and 2 ).
- Tensioning member 200 extends between first and second attachment ends 60 and 62 (shown in FIGS. 3 and 4 ) and in the exemplary embodiment, includes at least two anchoring loops 202 and 204 , and an adjustment mechanism 206 extending between loops 202 and 204 .
- loops 202 and 204 are each formed integrally with respective attachment ends 60 and 62 .
- loops 202 and 204 are coupled to ends 60 and 62 using any suitable coupling means.
- adjustment mechanism 206 enables each attachment end 60 and 62 to be coupled to a leaflet 34 (shown in FIGS. 1 and 2 ) and to any other cardiac structure other than a mitral valve leaflet 34 , without tension being induced to either end 60 or 62 . Moreover, once ends 60 and 62 are coupled to the leaflet 34 and the cardiac structure, adjustment mechanism 206 enables a pre-determined tension to be induced between the leaflet 34 and the cardiac structure.
- adjustment mechanism 206 functions similarly to a drawstring and includes a locking mechanism 220 that facilitates maintaining a desired tension between the leaflet 34 and the cardiac structure. More specifically, after ends 60 and 62 have each been securely coupled to the leaflet and the cardiac structure, as adjustment loop 222 is pulled away from ends 60 and 62 , adjustment mechanism 206 is drawn radially inward between ends 60 and 62 , inducing tension between the leaflet 34 and the cardiac structure, and locking mechanism 220 is coupled to adjustment loop 222 to facilitate ensuring that ends 60 and 62 are maintained in their relative position such that the tension induced between ends 60 and 62 is maintained.
- adjustment mechanism 206 does not include locking mechanism 222 , but rather any suitable method of maintaining the tension between ends 60 and 62 may be utilized, such as, but not limited to, self-locking twist fastener devices or swivel fasteners. Moreover, in a further embodiment, adjustment mechanism 206 does not include locking mechanism 220 , but rather the tension induced by the placement of loop 222 is maintained by a knot tied in position adjacent loop 222 .
- adjustment mechanisms other than mechanism 206 may be used, such as, but not limited to, the installation of a spreader bar mechanism within at least one loop of a daisy chained tension member, the use of a turnbuckle-type mechanism, and/or the use of tensioning member that is shortened as it is twisted, such as would be possible with a tourniquet-type attachment.
- at least a portion of adjustment mechanism 206 is fabricated from a shaped metal alloy that is formed into a component that when coupled within a fastener assembly either constricts or bows outwardly to induce tension between the ends 60 and 62 .
- FIG. 8 is a flowchart illustrating an exemplary method for the endovascular repair of a cardiac valve.
- the mitral valve, or other atrioventricular valve being repaired is accessed percutaneously 300 .
- the approach to the mitral valve may be “antegrade” and require entry into the left atrium by crossing the interatrial septum.
- approach to the mitral valve can be “retrograde” wherein the left ventricle is entered through the aortic valve.
- the interventional tools and supporting catheter(s) will be positioned 302 endovascularly adjacent the valve being repaired.
- the present invention may be used with open surgical techniques wherein the heart is stopped and the heart valve accessed through the myocardial tissue.
- the interventional tools used for performing the valve repairs may be specifically designed for use with the present invention, or existing tools may be modified to accommodate the present invention.
- a 1° catheter is used to position or guide a plurality of smaller catheters in which the 1° catheter is used to accomplish general positioning of the device relative to the valve being repaired, and the smaller catheters facilitate the more precise positioning necessary to repair the valve in accordance with the present invention.
- a guide catheter, a needle bearing catheter, an introducer, or a similar device may be used.
- the leaflet to be repaired is captured 310 and the first attachment end of the fastening mechanism is securely coupled to the leaflet 312 .
- the fastening mechanism may be coupled to the leaflet in a plurality of manners, but in each case, the first attachment end of the mechanism is securely coupled to the valve leaflet in need of repair.
- the leaflet may be captured 310 using any of a plurality of known methods, including, but not limited to using grasping pins, articulated graspers, vacuum-assisted graspers, or any other suitable method.
- the second attachment end of the fastening mechanism is then securely coupled 330 to a cardiac structure other than a mitral valve leaflet.
- the tension induced 332 to the mitral valve leaflet is selected to substantially simulate the same tension, operation, and functionality of a natural chordae member coupled to the leaflet.
- tension induced to the mitral valve leaflet is adjustable via adjustments of the tensioning member.
- TEE trans-esophegeal echocardiography
- ICE intracardiac echocardiography
- MRI catheter based magnetic resonance imaging
- CT computed tomography
Abstract
Apparatus for use in repairing an atrioventricular valve in a patient is provided. The apparatus comprises a fastening mechanism for use in repairing a mitral valve in the heart of a patient. The mechanism includes a first end, a second end, and a body extending therebetween. The mechanism is configured to be positioned in the patient's heart using at least one of a guide catheter and an interventional tool that positions the fastening mechanism without penetrating a myocardium. The first end is configured to couple to the valve leaflet while the heart is non-arrested. The second end is configured to couple to a structure other than the valve leaflet, such that the mechanism remains coupled within the heart after being coupled within the heart and simulates the function of a natural chordae.
Description
- This application is a continuation of U.S. patent application Ser. No. 11/287,011, filed Nov. 23, 2005. The parent patent application is incorporated herein by reference in its entirety.
- This invention relates generally to medical methods and apparatus, and more particularly, to methods and apparatus for the endovascular or minimally invasive surgical repair of atrioventricular valves of the heart, including the mitral valve and the tricuspid valve.
- The heart includes four valves that direct blood through the two sides of the heart. The mitral valve lies between the left atrium and the left ventricle and controls the flow of blood into the left side of the heart. The valve includes two leaflets, an anterior leaflet and a posterior leaflet, that close during systole. The leaflets are passive in that they open and close in response to pressure induced to the leaflets by the pumping of the heart. More specifically, during a normal cycle of heart contraction (systole), the mitral valve functions as a check valve to prevent the flow of oxygenated blood back into the left atrium. In this manner, oxygenated blood is pumped into the aorta through the aortic valve.
- Occasionally, the mitral valve is formed abnormally through a congenital condition. More often, however, the mitral valve degenerates with age. Among the problems that can develop is mitral valve regurgitation in which the mitral valve leaflets become unable to close properly during systole, thus enabling leakage to flow through the mitral valve during systole. Over time, regurgitation of the mitral valve can adversely affect cardiac function and may compromise a patient's quality of life and/or life-span.
- Mitral valve regurgitation can result from a number of different mechanical defects in the mitral valve. For example, the valve leaflets, the valve chordae which connect the leaflets to the papillary muscles, or the papillary muscles themselves may become damaged or otherwise dysfunctional. Moreover, the valve annulus may become damaged or weakened and may limit the ability of the mitral valve to close adequately during systole.
- Known treatments for mitral valve regurgitation commonly rely on valve replacement or annuloplasty, or strengthening of the mitral valve through surgical repairs and/or implanting a mechanical structure within the mitral valve. For example, the most prevalent and widely accepted known techniques to correct mitral valve regurgitation, repair the mitral valve via open heart surgery. During such an invasive surgical procedure, it is known to suture adjacent segments of the opposed valve leaflets together in a procedure known as a “bow-tie” or “edge-to-edge” surgical technique. Although each of the afore-mentioned treatments can be effective, generally known treatments rely on open heart surgery wherein the patient's chest is opened and the patient's heart is stopped while the patient is place on a cardiopulmonary bypass. The need to open the patient's chest and to place the patient on a cardiopulmonary bypass creates inherent risks that may be traumatic to the patient.
- Percutaneously treatments are less invasive than the treatments mentioned above, but such treatments may be less effective and more difficult to effect repair because of the limited amount of space in and around the mitral valve in which to maneuver a repair device or devices. For example, U.S. Pat. No. 6,875,224 to Grimes describes a percutaneous mitral valve repair method in which the opposed leaflets are each immobilized to enable the two leaflets to be fastened together. Furthermore, U.S. Pat. No. 6,6290,534 to St. Goar et al. describes a plurality of embodiments for use in endovascular repair of cardiac valves in which, in each embodiment, both leaflets are grasped and held firmly in position prior to permanent treatment. However, grasping both leaflets while the patient's heart is beating may be a time-consuming and laborious task that demands a coordinated effort on the part of the surgical team. Moreover, to facilitate grasping both leaflets percutaneously may require that the patient's heart be temporarily stopped or slowed by drugs or other techniques. Slowing and/or stopping the patient's heart during surgery may increase the risks to the patient.
- In one aspect, a method of repairing an atrioventricular valve in a patient is provided. The method comprises accessing the patient's atrioventricular valve percutaneously, securing a fastening mechanism to a valve leaflet, and coupling the valve leaflet, while the patient's heart remains beating, to at least one of a ventricular wall adjacent the atrioventricular valve, a papillary muscle, at least one valve chordae, and a valve annulus to facilitate reducing leakage through the valve.
- In another aspect, a method of repairing a mitral valve in the heart of a patient is provided. The method comprises accessing the patient's mitral valve percutaneously, securing a first end of a fastening mechanism to a valve leaflet of the mitral valve, and coupling a second end of the fastening mechanism to a cardiac structure other than a mitral valve leaflet to facilitate reducing leakage through the patient's mitral valve during ventricular systole.
- In a further aspect, a method of enhancing operation of a patient's heart valve is provided. The method comprises inserting a guide catheter along the venous system of the patient to approach the mitral valve, guiding a fastening mechanism towards one of a mitral valve and a tricuspid valve within the patient's heart, and securing a first end of the fastening mechanism to one of the mitral valve and the tricuspid valve using one of fusing, gluing, stapling, clipping, riveting, anchoring, and suturing. The method also comprises securing a second end of the fastening mechanism to a cardiac structure other than a valve leaflet to facilitate enhancing operation of the valve during ventricular systole.
- In an additional aspect, a medical kit for use in repairing a mitral valve is provided. The kit includes a guide catheter and a fastening mechanism. The guide catheter is configured for insertion along the venous system of the patient to approach the mitral valve. The fastening mechanism is positionable percutaneously within the patient using the guide catheter. The fastening mechanism includes a first end and an opposite second end. The first end is configured to couple to the mitral valve using one of fusing, gluing, stapling, clipping, riveting, anchoring, and suturing. The second end is configured to only couple to a cardiac structure other than a valve leaflet to facilitate enhancing operation of the valve during ventricular systole.
-
FIG. 1 is a cross-sectional view of the left and right ventricles of a human heart in diastole; -
FIG. 2 is an another cross-sectional view of the heart shown inFIG. 1 during systole; -
FIG. 3 is an exemplary schematic illustration of a fastening mechanism that may be used to facilitate repair of a cardiac valve within the heart shown inFIGS. 1 and 2 ; -
FIG. 4 is an enlarged view of a portion of the fastening mechanism shown inFIG. 1 and coupled to a papillary muscle in the heart shown inFIGS. 1 and 2 ; -
FIG. 5 is a schematic view of an alternative embodiment of a portion of a fastening mechanism that may be used to facilitate repair of a cardiac valve within the heart shown inFIGS. 1 and 2 ; -
FIG. 6 is a schematic view of an another alternative embodiment of a portion of a fastening mechanism that may be used to facilitate repair of a cardiac valve within the heart shown inFIGS. 1 and 2 ; -
FIG. 7 is a schematic view of a further alternative embodiment of a portion of a fastening mechanism that may be used to facilitate repair of a cardiac valve within the heart shown inFIGS. 1 and 2 ; and -
FIG. 8 is a flowchart illustrating an exemplary method for the endovascular repair of a cardiac valve. -
FIG. 1 is a cross-sectional view of the left andright ventricles human heart 14 during diastole.Ventricles interatrial septum 15.FIG. 2 is a cross-sectional view ofheart 14 during systole. The present invention provides methods and apparatus for the endovascular repair of cardiac valves, particularlyatrioventricular valves 16, which inhibit back-flow of blood from a heart ventricle during contraction (systole). In particular, the present invention may be used in repairing, but is not limited to repairing,mitral valves 20. - As used herein, the term “endovascular,” refers to procedure(s) of the present invention that are performed with interventional tools and supporting catheters and other equipment introduced to the heart chambers from the patient's arterial or venous vasculature remote from the heart. The interventional tools and other equipment may be introduced percutaneously, i.e., through an access sheath, or may be introduced via a surgical cut down, and then advanced from the remote access site through the vasculature until they reach
heart 14. As such, the methods and apparatus described herein generally do not require penetrations made directly through an exterior heart muscle, i.e., myocardium, although there may be some instances where penetrations will be made interior to the heart, e.g., through the interatrial septum to provide for a desired access route. Moreover, as will be appreciated by one of ordinary skill in the art, the methods and apparatus described herein are not limited to use with percutaneous and intravascular techniques, but rather the present invention may be used with open surgical procedures as well. - The
atrioventricular valves 16 are each located at a junction of the atria and their respective ventricles. Theatrioventricular valve 16 extending between theright atrium 30 and theright ventricle 12 has three valve leaflets (cusps) and is referred to as the tricuspid or rightatrioventricular valve 31. Theatrioventricular valve 16 between the left atrium 32 and theleft ventricle 10 is a bicuspid valve having only two leaflets orcusps 34 and is generally referred to as themitral valve 20. - During operation of the
heart 14, thevalve leaflets 34 open during diastole when the heart atria fill with blood, allowing the blood to pass into the ventricle. During systole, however, thevalve leaflets 34 are pushed together such that thefree edges 36 of theleaflets 34 are closed against each other along a line of coaptation to prevent the back-flow of blood into the atria. Back flow of blood or “regurgitation” through themitral valve 20 is facilitated to be prevented when theleaflets 34 are closed, such that themitral valve 20 functions as a “check valve” which prevents back-flow when pressure in theleft ventricle 10 is higher than that in the left atrium 32. - The
mitral valve leaflets 34 are attached to the surrounding heart structure along an annular region referred to as thevalve annulus 40. The free edges 36 of theleaflets 34 are secured to the lower portions of theleft ventricle 10 through tendon-like tissue structures, known as chordae tendineae orchordae 42. Thechordae 42 are attached to thepapillary muscles 44 which extend upwardly from the lower portions of the left ventricle andinterventricular septum 46. - A number of structural defects in the heart can cause mitral valve regurgitation. For example, ruptured
chordae 42 may cause avalve leaflet 34 to prolapse if inadequate tension is induced to theleaflet 34 through the remainingunruptured chordae 42. Moreover, and for example, regurgitation may also occur in patients suffering from cardiomyopathy, wherein theheart 14 is dilated and the increased size prevents the valve leaflet edges 36 from contacting each other properly, or in patients who have suffered ischemic heart disease wherein the functioning of thepapillary muscles 44 may be impaired. Generally during regurgitation thefree edges 36 of the anterior andposterior leaflets 34 do not contact sufficiently along the line of coaptation, but rather leakage may occur through a gap defined between theleaflets 34. -
FIG. 3 is an exemplary schematic illustration of afastening mechanism 50 that may be used to facilitate repair of anatrioventricular valve 16 within heart 14 (shown inFIGS. 1 and 2 ).FIG. 4 is an enlarged view of a portion of the fastening mechanism shown inFIG. 3 and coupled to apapillary muscle 44.Fastening mechanism 50 includes afirst attachment end 60 and asecond attachment end 62. In the exemplary embodiment,first attachment end 60 includes a generallydeformable clip portion 64 that is sized and shaped to couple to a free edge 36 (shown inFIGS. 1 and 2 ) of a leaflet 34 (shown inFIGS. 1 and 2 ). In alternative embodiments,first attachment end 60 is coupled to leaflet 34 without usingclip portion 64. - Overall dimensions of, and material properties used in fabricating,
clip portion 64 are variably selected based on theleaflet 34 being repaired. In the exemplary embodiment,portion 64 is pinched or crimped against a leafletfree edge 36 to facilitate repair of the valve as described in more detail below. More specifically, in this embodiment,fastening mechanism 50 is coupled tovalve 16 such that an outer surface of leafletfree edge 36 is grasped withoutmechanism 50 penetrating the leaflet tissue. Specifically, in the exemplary embodiment, the leafletfree edge 36 is crimped between opposingsides portion 64. In another embodiment,portion 64 is coupled to afree edge 36 using any suitable means that enablesportion 64 to remain coupled to leafletfree edge 36, such as, but not limited to, with gluing, stapling, suturing, fusing, riveting, external clips, or any combination thereof - Alternatively,
first attachment end 60 may be secured to leaflet 34 through atraumatic partial, or full penetration, or piercing ofleaflet 34. For example,first attachment end 60 and/orportion 64 may include attachment prongs that extend fromclip portion 64 and that are configured to pinch, partially penetrate, or pierce theleaflet 34. In one alternative embodiment,first attachment end 60 may be inserted from a first side of theleaflet 34, throughleaflet 34, and outward from an opposite second side of theleaflet 34. In such an embodiment, in usefirst attachment end 60 is coupled to, and secured against the second side of the leaflet. In another alternative embodiment, first attachment end is inserted only partially through theleaflet 34, and thus is secured to leaflet tissue intermediate the first and second sides of the leaflet. - In another alternative embodiment,
first attachment end 60 is attached to leaflet 34 using any suitable means that will enablefastening mechanism 50 to function as described herein, such as, but not limited to, an adhesive process, a riveting process, a suturing process, a stapling process, or any combination thereof. In a further alternative embodiment, a threaded locking member or any other suitable mechanical coupling, may be used to securefirst attachment end 60 to the leaflet. In another alternative embodiment,attachment end 60 may be fused directly to theleaflet 34 using a known fusion process in which laser, RF, microwave or ultrasonic energy, for example, is applied at specified coaptation points. - In the exemplary embodiment,
clip portion 64 is fabricated from a formable material that is coated in a protective cloth-like material.Clip portion 64 may be fabricated from any suitable biocompatible material that enablesfastening mechanism 50 to function as described herein, such as, but not limited to, titanium alloys, platinum alloys, stainless steel, or any combination thereof. In the exemplary embodiment,clip portion 64 is coated with a fabric material such as, but not limited to, a DACRON® material, a TEFLON® material, a GORE-TEX®, or any material or combination thereof that enablesclip portion 64 to function as described herein. In one embodiment,clip portion 64 is covered by a material that encourages tissue in-growth. - In the exemplary embodiment, a tensioning
member 70 extends fromclip portion 64 tosecond attachment end 62. The overall size, shape, and material used inmember 70 is variably selected depending on the application. For example, in one embodiment,member 70 is fabricated from a mesh material. The relative location ofmember 70 with respect to clipportion 64 is variably selected based on the amount of tension to be induced, the desired locations for the tension to be induced, and based on theleaflet 34 being repaired. - In the exemplary embodiment, tensioning
member 70 includes anattachment pad 74. The overall size, shape, thickness, and material used in fabricatingpad 74, as well as the number and location ofpad 74, are variably selected based on the intended use offastening mechanism 50. Alternatively,fastening mechanism 50 includes more than one tensioningmember 70. In another alternative embodiment,fastening mechanism 50 may include asingle tensioning member 70 that includes a forked or bifurcated end that includes twopads 74. In yet another alternative embodiment, fastening tensioningmember 70 does not includepad 74. In a further alternative embodiment,fastening mechanism 50 includes at least one tensioning member that is formed with a looped end that is sized to circumscribe the cardiac structure to which it is attached, and is cinchable to facilitate securingfastening mechanism 50 to thepapillary muscle 44. Tensioningmember 70 facilitates inducing tension to theleaflet 34 being repaired, andpad 74 facilitates distributing loading across thepapillary muscle 44. Moreover,pad 74 is sized for placement along an external surface ofpapillary muscle 44 when fasteningmechanism 50 is coupled to thepapillary muscle 44. - In the exemplary embodiment, tensioning
member 70 andpad 74 are formed integrally together. Alternatively, pad 74 may be securely coupled tomember 70 using any of a plurality of known coupling means. In the exemplary embodiment,member 70 is coupled topapillary muscle 44 using a fastener (not shown) that is inserted at least partially throughpapillary muscle 44. In one embodiment, the fastener has a tack-like configuration. In another embodiment, the fastener is mechanically coupled to thepapillary muscle 44 using, for example, a suitable threaded coupling. In a further embodiment, at least one of a pair of interlocking fasteners is inserted through apad 74 prior to insertion through thepapillary muscle 44 and prior to the two fasteners being interlocked. In another embodiment,pad 74 is coupled in position against thepapillary muscle 44 by a cinch-type fastener that circumscribes thepapillary muscle 44 when securely cinched. In another alternative embodiment,pad 74 is coupled directly to thepapillary muscle 44 using any suitable means that will enablefastening mechanism 50 to function as described herein, such as, but not limited to, an adhesive process, a riveting process, a suturing process, a coil or corkscrew device, a stapling process, external clips, or any combination thereof. In a further alternative embodiment, a threaded locking member and a self-locking or spin-lock ratcheting fastener may be used to securemember 70 to thepapillary muscle 44. In yet a further alternative embodiment,pad 74, and/or tensioningmember 70 is coupled to thepapillary muscle 44 using a flat ribbon that has been heat-set in the shape of double loops. -
Pad 74 andmember 70 may be fabricated from any material that enablespad 74 andmember 70 to function as described herein. For example,pad 74 andmember 70 may be fabricated from, but are not limited to being fabricated from, a DACRON® material, a TEFLON® material, a GORE-TEX®, or any material or combination. In addition, depending on the application,pad 74 andmember 70 may be fabricated from, but are not limited to being fabricated from a superelastic material or a shaped memory alloy (SMA) material, such as, but not limited, to Nitinol®, stainless steel, plastic, or any of several known shaped memory alloys (SMA) that have properties that develop a shaped memory effect (SME). In one embodiment,pad 74 is fabricated from a material that encourages tissue in-growth. - During use, to repair a
mitral valve 20 usingfastening mechanism 50,first attachment end 60 is coupled securely tomitral valve 20 andsecond attachment end 62 is coupled to a cardiac structure, such as thepapillary muscle 44. Alternatively,second attachment end 62 may be coupled to any cardiac structure other than amitral valve leaflet 34 such as, but not limited to, aventricular wall 46 adjacent theatrioventricular valve 30, avalve chordae 42, either intact or ruptured, avalve annulus 36, aninteratrial septum 15 or any combination thereof. In the exemplary embodiment,second attachment end 62 is coupled to thepapillary muscle 44. More specifically, whenend 62 is firmly secured to thepapillary muscle 44,pad 74 is retained tightly against the exterior surface of thepapillary muscle 44. As such, loading induced to the papillary muscle fromfastening mechanism 50 is distributed acrosspad 74. - In the exemplary embodiment, overall dimensions and material properties of
member 70 are variably selected to facilitate inducing a desired tension to leaflet 34 and to facilitate improving the ability of theatrioventricular valve 16 to close against the elevated pressures within the ventricle during systole. More specifically,member 70 is variably selected to facilitate modifying operation of theleaflet 34 such that the free ends 36 of theopposed leaflets 34 again contact each other during systole along the line of coaptation to prevent the back-flow or regurgitation of blood through themitral valve 20 into the atria. -
FIG. 5 is a schematic view of an alternative embodiment of a portion of a fastening mechanism 100 that may be used to facilitate repair of a cardiac valve 16 (shown inFIGS. 1 and 2 ). Fastening mechanism 100 is substantially similar to fastening mechanism 50 (shown inFIGS. 3 and 4 ) and, components of fastening mechanism 100 that are identical to components offastening mechanism 50 are identified inFIG. 5 using the same reference numerals used inFIGS. 3 and 4 . Accordingly, fastening mechanism 100 includesfirst attachment end 60, second attachment end 62 (shown inFIGS. 3 and 4 ), and at least one tensioning member 110 extending therebetween. In the exemplary embodiment, tensioning member 110 includes an anchor member 112. It should be noted that althoughattachment end 60 is illustrated, the anchor member 112 may also be included atattachment end 62 and/or end 60, or at any suitable location between ends 60 and 62 depending on the application. - Tensioning member 110 is substantially similar to tensioning
member 70 and as such, facilitates inducing tension to the leaflet 34 (shown inFIGS. 1 and 2 ) being repaired. In the exemplary embodiment, tensioning member 110 and anchor member 112 are formed integrally together. Alternatively, anchor member 112 may be securely coupled to tensioning member 110 using any of a plurality of known coupling means. In the exemplary embodiment, member 110 is coupled to leaflet 34 using anchor member 112, or any other cardiac structure other than amitral valve leaflet 34, such as, but not limited to, a ventricular wall 46 (shown inFIGS. 1 and 2 ) adjacent the atrioventricular valve 30 (shown inFIGS. 1 and 2 ), a valve chordae 42 (shown inFIGS. 1 and 2 ), either intact or ruptured, a valve annulus 36 (shown inFIGS. 1 and 2 ), an interatrial septum 15 (shown inFIGS. 1 and 2), a papillary muscle 44 (shown inFIGS. 1 , 2, and 4), or any combination thereof - In the exemplary embodiment, anchor member 112 has a distal end 114 that is pointed and is self-piercing that facilitates transmural attachment to a ventricular wall. Accordingly, the anchor member distal end 114 may be fabricated of any material having sufficient rigidity to pierce, and/or at least partially penetrate, through a portion of the cardiac component to which it is intended to be attached. For example, the distal end 114 may be fabricated from, but is not limited to being fabricated from, stainless steel, titanium, various shaped memory or superelastic materials, metal alloys, various polymers, and combinations thereof. Moreover, the geometries, tip sharpness, and dimensions of anchor member 112 are variably selected to ensure a desired amount of piercing, if any, occurs. In an alternative embodiment, the anchor member distal end 114 does not actually pierce the cardiac structure, but rather is positioned in a desired position by a surgical instrument, such as, but not limited to a piercing catheter or a needle.
- In the exemplary embodiment, anchor member 112 includes a plurality of anchoring arms 120 that are biased outwardly from tensioning member 110. Alternatively, anchor member 112 may include, but is not limited to including, a plurality of penetrating and/or non-penetrating petals, wings, propellers, coils, arms, ribbons, tubes, loops, grappling hooks, barbs, or clips, that are extend outwardly from tensioning member 110 to enable fastening mechanism 100 to function as described herein. Moreover, in other embodiments, anchor member 112 may include expandable arms that expand outwardly from a compressed state. For example, in one embodiment, the arms 120 function similarly to an umbrella and include a pleated, supported material member that is biased outwardly, as described herein. Furthermore, the cross-sectional shape of arms 120 is illustrated as exemplary only. Rather, anchor member 112, arms 120, and tensioning member 110 may be fabricated with any cross-sectional shape that enables fastening mechanism 100 to function as described herein.
- In the exemplary embodiment, arms 120 are biased outwardly such as is possible using pre-shaped, resilient metallic rods, for example. Alternatively, the arms 120 may be fabricated from any suitable material and in any suitable manner that enables arms 120 to function as described herein. For example, arms 120 may be fabricated from, but are not limited to being fabricated from Nitinol®, stainless steel, plastic, superelastic alloys, polymers, or any of several known shaped memory alloys (SMA) that have properties that develop a shaped memory effect (SME). Moreover, arms 120 may be fabricated from, but are not limited to being fabricated from, a DACRON® material, a TEFLON® material, a GORE-TEX®, or any material or combination. In one embodiment, arms 120 are fabricated from a material that encourages tissue in-growth.
- During installation, after distal end 114 has penetrated at least partially through the cardiac component to which it is being attached, arms 120 are advanced through the penetration or opening and are displaced outwardly. More specifically, as tensioning member 100 is withdrawn or retracted from the opening in an opposite direction to that of insertion within the opening, because arms 120 are biased outwardly from tensioning member 100. More specifically, the biasing of the arms 120 causes the arms 120 to contact the surface of the cardiac component radially outward from the opening, such that the arms 120 are not retractable through the opening as tensioning member 100 is withdrawn from the opening. Rather, as tensioning member 100 is withdrawn from the opening, anchor member 112 is secured against a tissue surface of the cardiac component.
-
FIG. 6 is a schematic view of an alternative embodiment of a portion of afastening mechanism 150 that may be used to facilitate repair of a cardiac valve 16 (shown inFIGS. 1 and 2 ).Fastening mechanism 150 is substantially similar tofastening mechanisms 50 and 100 (shown inFIGS. 3 and 4 , and 5, respectively) and, components offastening mechanism 150 that are identical to components offastening mechanism 50 and 100 are identified inFIG. 6 using the same reference numerals used inFIGS. 3-5 . Accordingly,fastening mechanism 150 includes first attachment end 60 (shown inFIGS. 3-5 ), second attachment end 62 (shown inFIGS. 3 and 4 ), and at least one tensioningmember 152 extending therebetween. In the exemplary embodiment, tensioningmember 152 includes ananchor member 156. It should be noted that althoughattachment end 62 is illustrated, theanchor member 156 may also be included atattachment end 60 and/or end 62, or at any suitable location between ends 60 and 62 depending on the application. - Tensioning
member 152 is substantially similar to tensioningmember 70, and/or tensioning member 110, and as such, facilitates inducing tension to the leaflet 34 (shown inFIGS. 1 and 2 ) being repaired. In the exemplary embodiment, tensioningmember 152 andanchor member 156 are formed integrally together. Alternatively,anchor member 156 may be securely coupled to tensioningmember 152 using any of a plurality of known coupling means. In the exemplary embodiment,member 152 is coupled to leaflet 34 usinganchor member 156, or any other cardiac structure other than amitral valve leaflet 34, such as, but not limited to, a ventricular wall 46 (shown inFIGS. 1 and 2 ) adjacent the atrioventricular valve 30 (shown inFIGS. 1 and 2 ), a valve chordae 42 (shown inFIGS. 1 and 2 ), either intact or ruptured, a valve annulus 36 (shown inFIGS. 1 and 2 ), an interatrial septum 15 (shown inFIGS. 1 and 2 ), a papillary muscle 44 (shown inFIGS. 1 , 2, and 4), or any combination thereof. - In the exemplary embodiment,
anchor member 156 is formed with a cork-screw or coil configuration and has adistal end 160 that is pointed and is self-piercing. Accordingly, theanchor member 156 may be fabricated of any material having sufficient rigidity to pierce, and/or at least partially penetrate, through a portion of the cardiac component to which it is intended to be attached. For example, thedistal end 156 may be fabricated from, but is not limited to being fabricated from, stainless steel, titanium, various shape memory or superelastic materials, metal alloys, various polymers, and combinations thereof. In an alternative embodiment, theanchor member 156 is not self-tapping, but rather is threadably coupled within a starter hole formed a surgical instrument, such as, but not limited to a piercing catheter or a needle. - In one embodiment,
anchor member 156 may be formed from a shape memory wire that is annealed or heat-set in a straight configuration and then coiled. In such an embodiment,anchor member 156 may be processed to have different properties by varying the diameter and tension therein along its length. For example, whenanchor member 156 is heated to a pre-determined temperature, such as with RF energy, a designated portion ofanchor member 156 will become a randomly oriented mass of material having self-locking struts to prevent disentanglement. When theanchor member 156 is heated to a different pre-determined temperature, a full entanglement of occurs such thatanchor member 156 is compressed together. - In an alternative embodiment,
anchor member 156 includes a plurality of tines or arms that are biased outwardly frommember 156, and more particularly fromtip 160. In such an embodiment, the arms facilitate securing theanchor member 156 in position within the cardiac structure to which it is embedded. Moreover, in other embodiments,anchor member 156 may include expandable arms that expand outwardly from a compressed state. Alternatively,anchor member 156 may include other self-locking struts that facilitate preventingmember 156 from backing out of the cardiac structure to which it is threadalby coupled. Furthermore, the cross-sectional shape ofanchor member 156 is illustrated as exemplary only. Rather,anchor member 156 and tensioningmember 152 may be fabricated with any cross-sectional shape, dimensions, or material that enablesfastening mechanism 150 to function as described herein. For example,anchor member 156 may be formed with, but is not limited to being formed with, a self-tapping screw configuration, a mesh configuration, or with a helical configuration. - Moreover, in another embodiment,
anchor member 156 is formed with a coiled configuration having a helical filament that includes a secondary helical structure that includes, for example, a plurality of loops. In such an embodiment,anchor member 156 may include an inner element fabricated from a shaped memory material and an outer element that is substantially concentrically aligned with respect to the inner element, and is fabricated from a second material, such as a radiopaque material or a heat-activated material. Furthermore, in other embodiments, to facilitate endovascular orientation, the coil may be fabricated with a stacked coil configuration in which no space is defined between adjacent windings of the coil, but rather, the coil assumes a coil configuration when heated to a pre-determined temperature as it is deployed. -
FIG. 7 is a schematic view of an alternative embodiment of a portion of atensioning member 200 that may be used to facilitate repair of a cardiac valve 16 (shown inFIGS. 1 and 2 ). Tensioningmember 200 extends between first and second attachment ends 60 and 62 (shown inFIGS. 3 and 4 ) and in the exemplary embodiment, includes at least two anchoringloops adjustment mechanism 206 extending betweenloops loops loops - In the exemplary embodiment,
adjustment mechanism 206 enables eachattachment end FIGS. 1 and 2 ) and to any other cardiac structure other than amitral valve leaflet 34, without tension being induced to either end 60 or 62. Moreover, once ends 60 and 62 are coupled to theleaflet 34 and the cardiac structure,adjustment mechanism 206 enables a pre-determined tension to be induced between theleaflet 34 and the cardiac structure. - In the exemplary embodiment,
adjustment mechanism 206 functions similarly to a drawstring and includes alocking mechanism 220 that facilitates maintaining a desired tension between theleaflet 34 and the cardiac structure. More specifically, after ends 60 and 62 have each been securely coupled to the leaflet and the cardiac structure, asadjustment loop 222 is pulled away from ends 60 and 62,adjustment mechanism 206 is drawn radially inward between ends 60 and 62, inducing tension between theleaflet 34 and the cardiac structure, andlocking mechanism 220 is coupled toadjustment loop 222 to facilitate ensuring that ends 60 and 62 are maintained in their relative position such that the tension induced between ends 60 and 62 is maintained. In an alternative embodiment,adjustment mechanism 206 does not includelocking mechanism 222, but rather any suitable method of maintaining the tension between ends 60 and 62 may be utilized, such as, but not limited to, self-locking twist fastener devices or swivel fasteners. Moreover, in a further embodiment,adjustment mechanism 206 does not includelocking mechanism 220, but rather the tension induced by the placement ofloop 222 is maintained by a knot tied in positionadjacent loop 222. - In alternative embodiments, other adjustment mechanisms other than
mechanism 206 may be used, such as, but not limited to, the installation of a spreader bar mechanism within at least one loop of a daisy chained tension member, the use of a turnbuckle-type mechanism, and/or the use of tensioning member that is shortened as it is twisted, such as would be possible with a tourniquet-type attachment. Moreover, in further alternative embodiments, at least a portion ofadjustment mechanism 206 is fabricated from a shaped metal alloy that is formed into a component that when coupled within a fastener assembly either constricts or bows outwardly to induce tension between theends -
FIG. 8 is a flowchart illustrating an exemplary method for the endovascular repair of a cardiac valve. Initially, the mitral valve, or other atrioventricular valve being repaired is accessed percutaneously 300. Depending on the point of vascular access, the approach to the mitral valve may be “antegrade” and require entry into the left atrium by crossing the interatrial septum. Alternatively, approach to the mitral valve can be “retrograde” wherein the left ventricle is entered through the aortic valve. Onceaccess 300 is achieved, the interventional tools and supporting catheter(s) will be positioned 302 endovascularly adjacent the valve being repaired. As will be appreciated by one of ordinary skill in the art, the present invention may be used with open surgical techniques wherein the heart is stopped and the heart valve accessed through the myocardial tissue. - The interventional tools used for performing the valve repairs may be specifically designed for use with the present invention, or existing tools may be modified to accommodate the present invention. For example, in one embodiment, a 1° catheter is used to position or guide a plurality of smaller catheters in which the 1° catheter is used to accomplish general positioning of the device relative to the valve being repaired, and the smaller catheters facilitate the more precise positioning necessary to repair the valve in accordance with the present invention. In other embodiments, a guide catheter, a needle bearing catheter, an introducer, or a similar device may be used.
- Once positioned 302, the leaflet to be repaired is captured 310 and the first attachment end of the fastening mechanism is securely coupled to the
leaflet 312. Specifically, as described above, the fastening mechanism may be coupled to the leaflet in a plurality of manners, but in each case, the first attachment end of the mechanism is securely coupled to the valve leaflet in need of repair. The leaflet may be captured 310 using any of a plurality of known methods, including, but not limited to using grasping pins, articulated graspers, vacuum-assisted graspers, or any other suitable method. - The second attachment end of the fastening mechanism is then securely coupled 330 to a cardiac structure other than a mitral valve leaflet. The tension induced 332 to the mitral valve leaflet is selected to substantially simulate the same tension, operation, and functionality of a natural chordae member coupled to the leaflet. In at least some embodiments, tension induced to the mitral valve leaflet is adjustable via adjustments of the tensioning member.
- After repairing the valve leaflet, flow through the valve can be observed by conventional cardiac imaging techniques, such as trans-esophegeal echocardiography (TEE), intracardiac echocardiography (ICE) or other ultrasonic imaging technique, fluoroscopy, angioscopy, catheter based magnetic resonance imaging (MRI), computed tomography (CT) and the like. By observing the flow through the repaired valves, it can be determined whether or not back flow or regurgitation has ceased, or whether the tension induced to the leaflet requires adjustment.
- Exemplary embodiments of methods and fastener mechanisms for use in repairing atrioventricular valves are described above in detail. Although the methods are herein described and illustrated in association with the above-described atrioventricular valve, it should be understood that the present invention may be used with any atrioventricular valve. More specifically, the fastener mechanisms and methods of repair are not limited to the specific embodiments described herein, but rather, aspects of each fastener mechanism and/or method of repair may be utilized independently and separately from other fastener mechanisms and/or repair methods.
- While the invention has been described in terms of various specific embodiments, those skilled in the art will recognize that the invention can be practiced with modification within the spirit and scope of the claims.
Claims (18)
1-31. (canceled)
32. A medical kit for use in repairing a mitral valve, said kit comprising:
a guide catheter configured for insertion along the arterial system of the patient to approach the mitral valve without penetrating through a myocardium; and
a fastening mechanism positionable endovascularly within the patient's heart using said guide catheter, said fastening mechanism comprising a first end and an opposite second end, said first end configured to couple to a leaflet of the mitral valve using one of fusing, gluing, stapling, clipping, riveting, anchoring, and suturing, said second end configured to only couple to a cardiac structure other than a valve leaflet to facilitate enhancing operation of the valve during ventricular systole, said fastening mechanism configured to remain securely coupled to the mitral valve leaflet and to and to at least one of a ventricular wall adjacent the atrioventricular valve, a papillary muscle, and a valve annulus, such that the fastening mechanism simulates the function of a native chordae after the guide catheter has been removed from the patient.
33. A medical kit in accordance with claim 32 wherein at least one of said fastening mechanism first and second ends comprises an anchor member comprising at least two arms.
34. A medical kit in accordance with claim 32 wherein at least a portion of said fastening mechanism is braided.
35. A medical kit in accordance with claim 32 wherein said fastening mechanism comprises at least one loop.
36. A medical kit in accordance with claim 32 wherein one of said fastening mechanism first end and said fastening mechanism second end comprises a helical coil.
37. A medical kit in accordance with claim 32 wherein said guide catheter comprises one of a mitral leaflet catheter, a cinching device, and a papillary muscle catheter.
38. A medical kit in accordance with claim 32 wherein said fastening mechanism is fabricated from at least one of a superelastic material, and a shaped memory alloy material.
39. A medical kit in accordance with claim 32 wherein one end of said fastening mechanism comprises a clip configured to couple to an edge of the mitral valve.
40. A medical kit in accordance with claim 32 wherein one end of said fastening mechanism comprises at least one adjustable loop.
41. A medical kit in accordance with claim 32 wherein said fastening mechanism first end is configured to couple to the mitral valve leaflet while the patient's heart remains beating.
42. A medical kit in accordance with claim 41 wherein said fastening mechanism second end is configured to couple to at least one of a ventricular wall adjacent the atrioventricular valve, a papillary muscle, and a valve annulus, while the patient's heart remains beating.
43. A medical kit in accordance with claim 32 wherein said fastening mechanism first end is sized to extend at least partially through an opening formed in the mitral valve leaflet.
44. A fastening mechanism for use in repairing a mitral valve in the heart of a patient by correcting an insufficiency of a valve leaflet of the mitral valve, wherein the valve is connected to at least one natural chordae, said fastening mechanism comprising:
a first end, a second end, and a body extending therebetween, said fastening mechanism configured to be positioned in the patient's heart using at least one of a guide catheter and an interventional tool that positions the fastening mechanism without penetrating a myocardium, said first end configured to couple to the valve leaflet while the heart is non-arrested, said second end configured to couple to a structure other than the valve leaflet, such that said fastening mechanism remains coupled within the heart after the at least one of a guide catheter and an interventional tool has been removed from the patient and simulates the function of a natural chordae.
45. The fastening mechanism in accordance with claim 44 wherein said fastening mechanism is fabricated from at least one of a superelastic material, and a shaped memory alloy material, said fastening mechanism facilitates reducing leakage through the patient's mitral valve.
46. The fastening mechanism in accordance with claim 44 wherein said fastening mechanism first end is configured to be at least one of fused, sutured, riveted, glued, and stapled to the mitral valve leaflet.
47. The fastening mechanism in accordance with claim 44 wherein said fastening mechanism second end is configured to be coupled to a cardiac structure other than the mitral valve leaflet via a fusing, a gluing, a riveting, and a stapling operation.
48. The fastening mechanism in accordance with claim 44 wherein said second end of the fastening mechanism is configured to be threadably coupled to the cardiac structure.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US13/280,112 US20120041548A1 (en) | 2005-11-23 | 2011-10-24 | Apparatus for atrioventricular valve repair |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US11/287,011 US8043368B2 (en) | 2005-11-23 | 2005-11-23 | Methods and apparatus for atrioventricular valve repair |
US13/280,112 US20120041548A1 (en) | 2005-11-23 | 2011-10-24 | Apparatus for atrioventricular valve repair |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US11/287,011 Continuation US8043368B2 (en) | 2005-11-23 | 2005-11-23 | Methods and apparatus for atrioventricular valve repair |
Publications (1)
Publication Number | Publication Date |
---|---|
US20120041548A1 true US20120041548A1 (en) | 2012-02-16 |
Family
ID=38054499
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US11/287,011 Expired - Fee Related US8043368B2 (en) | 2005-11-23 | 2005-11-23 | Methods and apparatus for atrioventricular valve repair |
US13/280,112 Abandoned US20120041548A1 (en) | 2005-11-23 | 2011-10-24 | Apparatus for atrioventricular valve repair |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US11/287,011 Expired - Fee Related US8043368B2 (en) | 2005-11-23 | 2005-11-23 | Methods and apparatus for atrioventricular valve repair |
Country Status (4)
Country | Link |
---|---|
US (2) | US8043368B2 (en) |
EP (1) | EP1951143A4 (en) |
CA (1) | CA2631752A1 (en) |
WO (1) | WO2007062128A2 (en) |
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9445899B2 (en) | 2012-08-22 | 2016-09-20 | Joseph M. Arcidi | Method and apparatus for mitral valve annuloplasty |
EP3003223A4 (en) * | 2013-06-05 | 2017-01-25 | LC Therapeutics, Inc. | Synthetic chord for cardiac valve repair applications |
WO2017205358A1 (en) * | 2016-05-24 | 2017-11-30 | Edwards Lifesciences Corporation | Posterior mitral valve leaflet approximation |
WO2018204518A1 (en) * | 2017-05-05 | 2018-11-08 | Edwards Lifesciences Corporation | Papillary muscle binding |
US11026791B2 (en) | 2018-03-20 | 2021-06-08 | Medtronic Vascular, Inc. | Flexible canopy valve repair systems and methods of use |
US11058538B2 (en) | 2016-03-10 | 2021-07-13 | Charles Somers Living Trust | Synthetic chord for cardiac valve repair applications |
US11147673B2 (en) | 2018-05-22 | 2021-10-19 | Boston Scientific Scimed, Inc. | Percutaneous papillary muscle relocation |
US11285003B2 (en) | 2018-03-20 | 2022-03-29 | Medtronic Vascular, Inc. | Prolapse prevention device and methods of use thereof |
Families Citing this family (155)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6626899B2 (en) * | 1999-06-25 | 2003-09-30 | Nidus Medical, Llc | Apparatus and methods for treating tissue |
US7976539B2 (en) | 2004-03-05 | 2011-07-12 | Hansen Medical, Inc. | System and method for denaturing and fixing collagenous tissue |
CN101495049B (en) | 2005-01-21 | 2010-12-15 | 梅约医学教育与研究基金会 | Thorascopic heart valve repair method and apparatus |
US20060229708A1 (en) * | 2005-02-07 | 2006-10-12 | Powell Ferolyn T | Methods, systems and devices for cardiac valve repair |
WO2011034973A2 (en) * | 2005-02-07 | 2011-03-24 | Abbott Vascular | Methods, systems and devices for cardiac valve repair |
US8608797B2 (en) | 2005-03-17 | 2013-12-17 | Valtech Cardio Ltd. | Mitral valve treatment techniques |
US8951285B2 (en) | 2005-07-05 | 2015-02-10 | Mitralign, Inc. | Tissue anchor, anchoring system and methods of using the same |
US20070118151A1 (en) * | 2005-11-21 | 2007-05-24 | The Brigham And Women's Hospital, Inc. | Percutaneous cardiac valve repair with adjustable artificial chordae |
US7632308B2 (en) * | 2005-11-23 | 2009-12-15 | Didier Loulmet | Methods, devices, and kits for treating mitral valve prolapse |
EP1959866B1 (en) | 2005-12-15 | 2019-03-06 | Georgia Tech Research Corporation | Papillary muscle position control devices and systems |
EP1968492A2 (en) * | 2005-12-15 | 2008-09-17 | Georgia Technology Research Corporation | Systems and methods to control the dimension of a heart valve |
CA2668988A1 (en) * | 2005-12-15 | 2007-09-07 | Georgia Tech Research Corporation | Systems and methods for enabling heart valve replacement |
ITTO20060413A1 (en) * | 2006-06-07 | 2007-12-08 | Arrigo Lessana | REPLACEMENT DEVICE OF THE TENDONE ROPES OF AN ATRIOVENTRICULAR VALVE |
US9974653B2 (en) | 2006-12-05 | 2018-05-22 | Valtech Cardio, Ltd. | Implantation of repair devices in the heart |
US11259924B2 (en) | 2006-12-05 | 2022-03-01 | Valtech Cardio Ltd. | Implantation of repair devices in the heart |
US11660190B2 (en) | 2007-03-13 | 2023-05-30 | Edwards Lifesciences Corporation | Tissue anchors, systems and methods, and devices |
WO2008149355A2 (en) * | 2007-06-04 | 2008-12-11 | Mor Research Applications Ltd. | Cardiac valve leaflet augmentation |
ES2336735B1 (en) * | 2007-07-17 | 2011-01-03 | Francisco J. Ilerimplant, S.L. | DEVICE TO REPAIR THE INSUFFICIENCY OF THE MITRAL VALVE. |
DE102007043830A1 (en) | 2007-09-13 | 2009-04-02 | Lozonschi, Lucian, Madison | Heart valve stent |
US20090088837A1 (en) * | 2007-09-28 | 2009-04-02 | The Cleveland Clinic Foundation | Prosthetic chordae assembly and method of use |
CN101902975B (en) | 2007-10-18 | 2014-06-04 | 尼奥绰德有限公司 | Minimally invasive repair of a valve leaflet in a beating heart |
US8382829B1 (en) | 2008-03-10 | 2013-02-26 | Mitralign, Inc. | Method to reduce mitral regurgitation by cinching the commissure of the mitral valve |
DK3967274T3 (en) * | 2008-04-23 | 2022-10-03 | Medtronic Inc | HEART VALVE DEVICES WITH STENT |
EP2296744B1 (en) | 2008-06-16 | 2019-07-31 | Valtech Cardio, Ltd. | Annuloplasty devices |
US20100023118A1 (en) * | 2008-07-24 | 2010-01-28 | Edwards Lifesciences Corporation | Method and apparatus for repairing or replacing chordae tendinae |
US8778016B2 (en) * | 2008-08-14 | 2014-07-15 | Edwards Lifesciences Corporation | Method and apparatus for repairing or replacing chordae tendinae |
US8911494B2 (en) | 2009-05-04 | 2014-12-16 | Valtech Cardio, Ltd. | Deployment techniques for annuloplasty ring |
US9011530B2 (en) | 2008-12-22 | 2015-04-21 | Valtech Cardio, Ltd. | Partially-adjustable annuloplasty structure |
EP2379008B1 (en) | 2008-12-22 | 2021-02-17 | Valtech Cardio, Ltd. | Adjustable annuloplasty devices |
US8715342B2 (en) | 2009-05-07 | 2014-05-06 | Valtech Cardio, Ltd. | Annuloplasty ring with intra-ring anchoring |
US8241351B2 (en) | 2008-12-22 | 2012-08-14 | Valtech Cardio, Ltd. | Adjustable partial annuloplasty ring and mechanism therefor |
US8808368B2 (en) * | 2008-12-22 | 2014-08-19 | Valtech Cardio, Ltd. | Implantation of repair chords in the heart |
US10517719B2 (en) | 2008-12-22 | 2019-12-31 | Valtech Cardio, Ltd. | Implantation of repair devices in the heart |
US8147542B2 (en) | 2008-12-22 | 2012-04-03 | Valtech Cardio, Ltd. | Adjustable repair chords and spool mechanism therefor |
US20110011917A1 (en) * | 2008-12-31 | 2011-01-20 | Hansen Medical, Inc. | Methods, devices, and kits for treating valve prolapse |
US20100210899A1 (en) * | 2009-01-21 | 2010-08-19 | Tendyne Medical, Inc. | Method for percutaneous lateral access to the left ventricle for treatment of mitral insufficiency by papillary muscle alignment |
EP2381852A4 (en) * | 2009-01-21 | 2014-06-11 | Tendyne Medical Inc | Apical papillary muscle attachment for left ventricular reduction |
US8353956B2 (en) | 2009-02-17 | 2013-01-15 | Valtech Cardio, Ltd. | Actively-engageable movement-restriction mechanism for use with an annuloplasty structure |
US8439969B2 (en) * | 2009-03-31 | 2013-05-14 | The Cleveland Clinic Foundation | Pre-sized prosthetic chordae implantation system |
US9968452B2 (en) | 2009-05-04 | 2018-05-15 | Valtech Cardio, Ltd. | Annuloplasty ring delivery cathethers |
US20120179184A1 (en) * | 2009-09-15 | 2012-07-12 | Boris Orlov | Heart valve remodeling |
US10098737B2 (en) | 2009-10-29 | 2018-10-16 | Valtech Cardio, Ltd. | Tissue anchor for annuloplasty device |
US9011520B2 (en) | 2009-10-29 | 2015-04-21 | Valtech Cardio, Ltd. | Tissue anchor for annuloplasty device |
US8940042B2 (en) * | 2009-10-29 | 2015-01-27 | Valtech Cardio, Ltd. | Apparatus for guide-wire based advancement of a rotation assembly |
US9180007B2 (en) | 2009-10-29 | 2015-11-10 | Valtech Cardio, Ltd. | Apparatus and method for guide-wire based advancement of an adjustable implant |
WO2011067770A1 (en) | 2009-12-02 | 2011-06-09 | Valtech Cardio, Ltd. | Delivery tool for implantation of spool assembly coupled to a helical anchor |
US8870950B2 (en) | 2009-12-08 | 2014-10-28 | Mitral Tech Ltd. | Rotation-based anchoring of an implant |
EP2509538B1 (en) | 2009-12-08 | 2017-09-20 | Avalon Medical Ltd. | Device and system for transcatheter mitral valve replacement |
US9107749B2 (en) | 2010-02-03 | 2015-08-18 | Edwards Lifesciences Corporation | Methods for treating a heart |
US8790394B2 (en) | 2010-05-24 | 2014-07-29 | Valtech Cardio, Ltd. | Adjustable artificial chordeae tendineae with suture loops |
US11653910B2 (en) | 2010-07-21 | 2023-05-23 | Cardiovalve Ltd. | Helical anchor implantation |
US9044221B2 (en) | 2010-12-29 | 2015-06-02 | Neochord, Inc. | Exchangeable system for minimally invasive beating heart repair of heart valve leaflets |
EP4119095A1 (en) | 2011-03-21 | 2023-01-18 | Cephea Valve Technologies, Inc. | Disk-based valve apparatus |
US9668860B2 (en) | 2011-04-04 | 2017-06-06 | The Medical Research, Infrastructure, and Health Services Fun of Tel Aviv Medical Center | Device and method for heart valve repair |
EP2713894B1 (en) | 2011-06-01 | 2021-01-20 | NeoChord, Inc. | System for minimally invasive repair of heart valve leaflets |
US10792152B2 (en) | 2011-06-23 | 2020-10-06 | Valtech Cardio, Ltd. | Closed band for percutaneous annuloplasty |
WO2013003228A1 (en) | 2011-06-27 | 2013-01-03 | University Of Maryland, Baltimore | Transapical mitral valve repair device |
CA3040390C (en) | 2011-08-11 | 2022-03-15 | Tendyne Holdings, Inc. | Improvements for prosthetic valves and related inventions |
US8858623B2 (en) | 2011-11-04 | 2014-10-14 | Valtech Cardio, Ltd. | Implant having multiple rotational assemblies |
EP3656434B1 (en) | 2011-11-08 | 2021-10-20 | Valtech Cardio, Ltd. | Controlled steering functionality for implant-delivery tool |
US9827092B2 (en) | 2011-12-16 | 2017-11-28 | Tendyne Holdings, Inc. | Tethers for prosthetic mitral valve |
FR2986149B1 (en) * | 2012-01-26 | 2014-12-26 | Ct Hospitalier Universitaire De Clermont Fd | DEVICE FOR REPLACING AT LEAST ONE CORDAGE OF THE MITRAL VALVE AND KIT COMPRISING AT LEAST TWO DEVICES |
US10076414B2 (en) | 2012-02-13 | 2018-09-18 | Mitraspan, Inc. | Method and apparatus for repairing a mitral valve |
EP2814428A4 (en) | 2012-02-13 | 2016-05-25 | Mitraspan Inc | Method and apparatus for repairing a mitral valve |
US20130289391A1 (en) * | 2012-04-27 | 2013-10-31 | Volcano Corporation | System and Method Using Forward Looking Imaging for Valve Therapies |
WO2014022124A1 (en) | 2012-07-28 | 2014-02-06 | Tendyne Holdings, Inc. | Improved multi-component designs for heart valve retrieval device, sealing structures and stent assembly |
WO2014021905A1 (en) | 2012-07-30 | 2014-02-06 | Tendyne Holdings, Inc. | Improved delivery systems and methods for transcatheter prosthetic valves |
US10022224B2 (en) | 2012-08-17 | 2018-07-17 | On-X Life Technologies, Inc. | Biological chord repair system and methods |
WO2014052818A1 (en) | 2012-09-29 | 2014-04-03 | Mitralign, Inc. | Plication lock delivery system and method of use thereof |
WO2014064694A2 (en) | 2012-10-23 | 2014-05-01 | Valtech Cardio, Ltd. | Controlled steering functionality for implant-delivery tool |
US10376266B2 (en) | 2012-10-23 | 2019-08-13 | Valtech Cardio, Ltd. | Percutaneous tissue anchor techniques |
US9023099B2 (en) | 2012-10-31 | 2015-05-05 | Medtronic Vascular Galway Limited | Prosthetic mitral valve and delivery method |
US9730793B2 (en) | 2012-12-06 | 2017-08-15 | Valtech Cardio, Ltd. | Techniques for guide-wire based advancement of a tool |
EP2948103B1 (en) | 2013-01-24 | 2022-12-07 | Cardiovalve Ltd | Ventricularly-anchored prosthetic valves |
EP2961351B1 (en) | 2013-02-26 | 2018-11-28 | Mitralign, Inc. | Devices for percutaneous tricuspid valve repair |
US10449333B2 (en) | 2013-03-14 | 2019-10-22 | Valtech Cardio, Ltd. | Guidewire feeder |
US9724195B2 (en) | 2013-03-15 | 2017-08-08 | Mitralign, Inc. | Translation catheters and systems |
US9486306B2 (en) | 2013-04-02 | 2016-11-08 | Tendyne Holdings, Inc. | Inflatable annular sealing device for prosthetic mitral valve |
US11224510B2 (en) | 2013-04-02 | 2022-01-18 | Tendyne Holdings, Inc. | Prosthetic heart valve and systems and methods for delivering the same |
US10463489B2 (en) | 2013-04-02 | 2019-11-05 | Tendyne Holdings, Inc. | Prosthetic heart valve and systems and methods for delivering the same |
US10478293B2 (en) | 2013-04-04 | 2019-11-19 | Tendyne Holdings, Inc. | Retrieval and repositioning system for prosthetic heart valve |
US9610159B2 (en) | 2013-05-30 | 2017-04-04 | Tendyne Holdings, Inc. | Structural members for prosthetic mitral valves |
CN105658178B (en) | 2013-06-25 | 2018-05-08 | 坦迪尼控股股份有限公司 | Feature is complied with thrombus management and structure for prosthetic heart valve |
US9561103B2 (en) | 2013-07-17 | 2017-02-07 | Cephea Valve Technologies, Inc. | System and method for cardiac valve repair and replacement |
CA2919379C (en) | 2013-08-01 | 2021-03-30 | Tendyne Holdings, Inc. | Epicardial anchor devices and methods |
US10070857B2 (en) | 2013-08-31 | 2018-09-11 | Mitralign, Inc. | Devices and methods for locating and implanting tissue anchors at mitral valve commissure |
WO2015058039A1 (en) | 2013-10-17 | 2015-04-23 | Robert Vidlund | Apparatus and methods for alignment and deployment of intracardiac devices |
US10299793B2 (en) | 2013-10-23 | 2019-05-28 | Valtech Cardio, Ltd. | Anchor magazine |
JP6554094B2 (en) | 2013-10-28 | 2019-07-31 | テンダイン ホールディングス,インコーポレイテッド | Prosthetic heart valve and system and method for delivering an artificial heart valve |
US9526611B2 (en) | 2013-10-29 | 2016-12-27 | Tendyne Holdings, Inc. | Apparatus and methods for delivery of transcatheter prosthetic valves |
US9610162B2 (en) | 2013-12-26 | 2017-04-04 | Valtech Cardio, Ltd. | Implantation of flexible implant |
US9681864B1 (en) | 2014-01-03 | 2017-06-20 | Harpoon Medical, Inc. | Method and apparatus for transapical procedures on a mitral valve |
WO2015120122A2 (en) | 2014-02-05 | 2015-08-13 | Robert Vidlund | Apparatus and methods for transfemoral delivery of prosthetic mitral valve |
US9986993B2 (en) | 2014-02-11 | 2018-06-05 | Tendyne Holdings, Inc. | Adjustable tether and epicardial pad system for prosthetic heart valve |
CA2937566C (en) | 2014-03-10 | 2023-09-05 | Tendyne Holdings, Inc. | Devices and methods for positioning and monitoring tether load for prosthetic mitral valve |
US10195030B2 (en) | 2014-10-14 | 2019-02-05 | Valtech Cardio, Ltd. | Leaflet-restraining techniques |
EP3229736B1 (en) | 2014-12-09 | 2024-01-10 | Cephea Valve Technologies, Inc. | Replacement cardiac valves and method of manufacture |
JP6826035B2 (en) | 2015-01-07 | 2021-02-03 | テンダイン ホールディングス,インコーポレイテッド | Artificial mitral valve, and devices and methods for its delivery |
AU2016215197B2 (en) | 2015-02-05 | 2020-01-02 | Tendyne Holdings Inc. | Expandable epicardial pads and devices and methods for their delivery |
EP3253333B1 (en) | 2015-02-05 | 2024-04-03 | Cardiovalve Ltd | Prosthetic valve with axially-sliding frames |
JP6669780B2 (en) | 2015-02-23 | 2020-03-18 | シー・アール・バード・インコーポレーテッドC R Bard Incorporated | Access sheath, access system, and related methods |
US20160256269A1 (en) | 2015-03-05 | 2016-09-08 | Mitralign, Inc. | Devices for treating paravalvular leakage and methods use thereof |
EP4070763A1 (en) | 2015-04-16 | 2022-10-12 | Tendyne Holdings, Inc. | Apparatus for retrieval of transcathter prosthetic valves |
CN114515173A (en) | 2015-04-30 | 2022-05-20 | 瓦尔泰克卡迪欧有限公司 | Valvuloplasty techniques |
EP3294220B1 (en) | 2015-05-14 | 2023-12-06 | Cephea Valve Technologies, Inc. | Cardiac valve delivery devices and systems |
AU2016262564B2 (en) | 2015-05-14 | 2020-11-05 | Cephea Valve Technologies, Inc. | Replacement mitral valves |
US11357499B2 (en) | 2015-08-18 | 2022-06-14 | Lsi Solutions, Inc. | Apparatus for mitral valve repair and methods thereof |
US10327894B2 (en) | 2015-09-18 | 2019-06-25 | Tendyne Holdings, Inc. | Methods for delivery of prosthetic mitral valves |
WO2017059406A1 (en) | 2015-10-01 | 2017-04-06 | Neochord, Inc. | Ringless web for repair of heart valves |
EP3753498B1 (en) | 2015-10-02 | 2023-12-06 | Harpoon Medical, Inc. | Distal anchor apparatus for mitral valve repair |
AU2016362474B2 (en) | 2015-12-03 | 2021-04-22 | Tendyne Holdings, Inc. | Frame features for prosthetic mitral valves |
AU2016380259B2 (en) | 2015-12-28 | 2020-10-22 | Tendyne Holdings, Inc. | Atrial pocket closures for prosthetic heart valves |
US10751182B2 (en) | 2015-12-30 | 2020-08-25 | Edwards Lifesciences Corporation | System and method for reshaping right heart |
WO2017117370A2 (en) | 2015-12-30 | 2017-07-06 | Mitralign, Inc. | System and method for reducing tricuspid regurgitation |
US10531866B2 (en) | 2016-02-16 | 2020-01-14 | Cardiovalve Ltd. | Techniques for providing a replacement valve and transseptal communication |
USD816215S1 (en) | 2016-02-23 | 2018-04-24 | C.R. Bard Inc. | Access device |
US10624743B2 (en) | 2016-04-22 | 2020-04-21 | Edwards Lifesciences Corporation | Beating-heart mitral valve chordae replacement |
US10470877B2 (en) | 2016-05-03 | 2019-11-12 | Tendyne Holdings, Inc. | Apparatus and methods for anterior valve leaflet management |
US10702274B2 (en) | 2016-05-26 | 2020-07-07 | Edwards Lifesciences Corporation | Method and system for closing left atrial appendage |
EP3468480B1 (en) | 2016-06-13 | 2023-01-11 | Tendyne Holdings, Inc. | Sequential delivery of two-part prosthetic mitral valve |
US11331187B2 (en) | 2016-06-17 | 2022-05-17 | Cephea Valve Technologies, Inc. | Cardiac valve delivery devices and systems |
EP3478224B1 (en) | 2016-06-30 | 2022-11-02 | Tendyne Holdings, Inc. | Prosthetic heart valves and apparatus for delivery of same |
GB201611910D0 (en) | 2016-07-08 | 2016-08-24 | Valtech Cardio Ltd | Adjustable annuloplasty device with alternating peaks and troughs |
EP3484411A1 (en) | 2016-07-12 | 2019-05-22 | Tendyne Holdings, Inc. | Apparatus and methods for trans-septal retrieval of prosthetic heart valves |
WO2018029680A1 (en) | 2016-08-10 | 2018-02-15 | Mitraltech Ltd. | Prosthetic valve with concentric frames |
AU2018203053B2 (en) | 2017-01-23 | 2020-03-05 | Cephea Valve Technologies, Inc. | Replacement mitral valves |
CR20190381A (en) | 2017-01-23 | 2019-09-27 | Cephea Valve Tech Inc | Replacement mitral valves |
US10213306B2 (en) | 2017-03-31 | 2019-02-26 | Neochord, Inc. | Minimally invasive heart valve repair in a beating heart |
US10765515B2 (en) | 2017-04-06 | 2020-09-08 | University Of Maryland, Baltimore | Distal anchor apparatus and methods for mitral valve repair |
US11045627B2 (en) | 2017-04-18 | 2021-06-29 | Edwards Lifesciences Corporation | Catheter system with linear actuation control mechanism |
SG11201912367UA (en) | 2017-06-19 | 2020-01-30 | Harpoon Medical Inc | Method and apparatus for cardiac procedures |
WO2019014473A1 (en) | 2017-07-13 | 2019-01-17 | Tendyne Holdings, Inc. | Prosthetic heart valves and apparatus and methods for delivery of same |
WO2019046099A1 (en) | 2017-08-28 | 2019-03-07 | Tendyne Holdings, Inc. | Prosthetic heart valves with tether coupling features |
CN111386083A (en) | 2017-10-20 | 2020-07-07 | 爱德华兹生命科学公司 | Local fusion of native leaflets using activated adhesive |
US11065120B2 (en) | 2017-10-24 | 2021-07-20 | University Of Maryland, Baltimore | Method and apparatus for cardiac procedures |
US10835221B2 (en) | 2017-11-02 | 2020-11-17 | Valtech Cardio, Ltd. | Implant-cinching devices and systems |
US11135062B2 (en) | 2017-11-20 | 2021-10-05 | Valtech Cardio Ltd. | Cinching of dilated heart muscle |
CN111655200B (en) | 2018-01-24 | 2023-07-14 | 爱德华兹生命科学创新(以色列)有限公司 | Contraction of annuloplasty structures |
WO2019145941A1 (en) | 2018-01-26 | 2019-08-01 | Valtech Cardio, Ltd. | Techniques for facilitating heart valve tethering and chord replacement |
EP3768176B1 (en) | 2018-03-23 | 2024-03-20 | NeoChord, Inc. | Device for suture attachment for minimally invasive heart valve repair |
US11517435B2 (en) | 2018-05-04 | 2022-12-06 | Edwards Lifesciences Corporation | Ring-based prosthetic cardiac valve |
US11253360B2 (en) | 2018-05-09 | 2022-02-22 | Neochord, Inc. | Low profile tissue anchor for minimally invasive heart valve repair |
US11173030B2 (en) | 2018-05-09 | 2021-11-16 | Neochord, Inc. | Suture length adjustment for minimally invasive heart valve repair |
US11224418B2 (en) * | 2018-06-15 | 2022-01-18 | Edwards Lifesciences Corporation | Papillary muscle approximation pads |
CA3106104A1 (en) | 2018-07-12 | 2020-01-16 | Valtech Cardio, Ltd. | Annuloplasty systems and locking tools therefor |
CN113194854A (en) | 2018-09-07 | 2021-07-30 | 尼奥绰德有限公司 | Suture attachment device for minimally invasive heart valve repair |
US11413147B2 (en) | 2018-10-03 | 2022-08-16 | Edwards Lifesciences Corporation | Ventricular remodeling using coil devices |
US11413146B2 (en) | 2018-10-03 | 2022-08-16 | Edwards Lifesciences Corporation | Spring and coil devices for papillary muscle approximation and ventricle remodeling |
US11376126B2 (en) | 2019-04-16 | 2022-07-05 | Neochord, Inc. | Transverse helical cardiac anchor for minimally invasive heart valve repair |
EP3962417A4 (en) | 2019-05-02 | 2023-01-18 | University of Maryland, Baltimore | Valve translocation device and method for the treatment of functional valve regurgitation |
CN114786621A (en) | 2019-10-29 | 2022-07-22 | 爱德华兹生命科学创新(以色列)有限公司 | Annuloplasty and tissue anchoring techniques |
US11648110B2 (en) | 2019-12-05 | 2023-05-16 | Tendyne Holdings, Inc. | Braided anchor for mitral valve |
US11648114B2 (en) | 2019-12-20 | 2023-05-16 | Tendyne Holdings, Inc. | Distally loaded sheath and loading funnel |
US11678980B2 (en) | 2020-08-19 | 2023-06-20 | Tendyne Holdings, Inc. | Fully-transseptal apical pad with pulley for tensioning |
CN114569291B (en) | 2022-05-07 | 2022-08-23 | 杭州德晋医疗科技有限公司 | Atrioventricular valve clamping device and atrioventricular valve clamping system |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20030105519A1 (en) * | 1997-09-04 | 2003-06-05 | Roland Fasol | Artificial chordae replacement |
US6629534B1 (en) * | 1999-04-09 | 2003-10-07 | Evalve, Inc. | Methods and apparatus for cardiac valve repair |
Family Cites Families (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6332893B1 (en) | 1997-12-17 | 2001-12-25 | Myocor, Inc. | Valve to myocardium tension members device and method |
US6926730B1 (en) | 2000-10-10 | 2005-08-09 | Medtronic, Inc. | Minimally invasive valve repair procedure and apparatus |
US20050070999A1 (en) * | 2000-02-02 | 2005-03-31 | Spence Paul A. | Heart valve repair apparatus and methods |
US20050125011A1 (en) * | 2001-04-24 | 2005-06-09 | Spence Paul A. | Tissue fastening systems and methods utilizing magnetic guidance |
WO2002102237A2 (en) * | 2001-06-15 | 2002-12-27 | The Cleveland Clinic Foundation | Tissue engineered mitral valve chrodae and methods of making and using same |
US7144363B2 (en) * | 2001-10-16 | 2006-12-05 | Extensia Medical, Inc. | Systems for heart treatment |
GB0125925D0 (en) * | 2001-10-29 | 2001-12-19 | Univ Glasgow | Mitral valve prosthesis |
US20030120341A1 (en) * | 2001-12-21 | 2003-06-26 | Hani Shennib | Devices and methods of repairing cardiac valves |
US8287555B2 (en) * | 2003-02-06 | 2012-10-16 | Guided Delivery Systems, Inc. | Devices and methods for heart valve repair |
US20050240202A1 (en) * | 2004-04-21 | 2005-10-27 | Hani Shennib | Devices and methods of repairing cardiac valves |
WO2006041877A2 (en) | 2004-10-05 | 2006-04-20 | Ample Medical, Inc. | Atrioventricular valve annulus repair systems and methods including retro-chordal anchors |
US20070118151A1 (en) | 2005-11-21 | 2007-05-24 | The Brigham And Women's Hospital, Inc. | Percutaneous cardiac valve repair with adjustable artificial chordae |
US7632308B2 (en) * | 2005-11-23 | 2009-12-15 | Didier Loulmet | Methods, devices, and kits for treating mitral valve prolapse |
US7635386B1 (en) * | 2006-03-07 | 2009-12-22 | University Of Maryland, Baltimore | Methods and devices for performing cardiac valve repair |
US20080228272A1 (en) * | 2006-12-04 | 2008-09-18 | Micardia Corporation | Dynamically adjustable suture and chordae tendinae |
US20100023118A1 (en) * | 2008-07-24 | 2010-01-28 | Edwards Lifesciences Corporation | Method and apparatus for repairing or replacing chordae tendinae |
-
2005
- 2005-11-23 US US11/287,011 patent/US8043368B2/en not_active Expired - Fee Related
-
2006
- 2006-11-22 EP EP06838280A patent/EP1951143A4/en not_active Withdrawn
- 2006-11-22 WO PCT/US2006/045217 patent/WO2007062128A2/en active Application Filing
- 2006-11-22 CA CA002631752A patent/CA2631752A1/en not_active Abandoned
-
2011
- 2011-10-24 US US13/280,112 patent/US20120041548A1/en not_active Abandoned
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20030105519A1 (en) * | 1997-09-04 | 2003-06-05 | Roland Fasol | Artificial chordae replacement |
US6629534B1 (en) * | 1999-04-09 | 2003-10-07 | Evalve, Inc. | Methods and apparatus for cardiac valve repair |
Cited By (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9445899B2 (en) | 2012-08-22 | 2016-09-20 | Joseph M. Arcidi | Method and apparatus for mitral valve annuloplasty |
EP3003223A4 (en) * | 2013-06-05 | 2017-01-25 | LC Therapeutics, Inc. | Synthetic chord for cardiac valve repair applications |
US11058538B2 (en) | 2016-03-10 | 2021-07-13 | Charles Somers Living Trust | Synthetic chord for cardiac valve repair applications |
WO2017205358A1 (en) * | 2016-05-24 | 2017-11-30 | Edwards Lifesciences Corporation | Posterior mitral valve leaflet approximation |
WO2018204518A1 (en) * | 2017-05-05 | 2018-11-08 | Edwards Lifesciences Corporation | Papillary muscle binding |
US11026791B2 (en) | 2018-03-20 | 2021-06-08 | Medtronic Vascular, Inc. | Flexible canopy valve repair systems and methods of use |
US11285003B2 (en) | 2018-03-20 | 2022-03-29 | Medtronic Vascular, Inc. | Prolapse prevention device and methods of use thereof |
US11701228B2 (en) | 2018-03-20 | 2023-07-18 | Medtronic Vascular, Inc. | Flexible canopy valve repair systems and methods of use |
US11931261B2 (en) | 2018-03-20 | 2024-03-19 | Medtronic Vascular, Inc. | Prolapse prevention device and methods of use thereof |
US11147673B2 (en) | 2018-05-22 | 2021-10-19 | Boston Scientific Scimed, Inc. | Percutaneous papillary muscle relocation |
US11678988B2 (en) | 2018-05-22 | 2023-06-20 | Boston Scientific Scimed, Inc. | Percutaneous papillary muscle relocation |
Also Published As
Publication number | Publication date |
---|---|
US8043368B2 (en) | 2011-10-25 |
EP1951143A2 (en) | 2008-08-06 |
CA2631752A1 (en) | 2007-05-31 |
WO2007062128A3 (en) | 2007-10-18 |
US20070118154A1 (en) | 2007-05-24 |
EP1951143A4 (en) | 2011-01-12 |
WO2007062128A2 (en) | 2007-05-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US8043368B2 (en) | Methods and apparatus for atrioventricular valve repair | |
US20230277169A1 (en) | Systems and methods for anchoring an implant | |
JP7136806B2 (en) | Method and device for transvascular implantation of newly formed chordae tendineae | |
US8187299B2 (en) | Methods and apparatus for cardiac valve repair | |
AU2003282982B2 (en) | Method and apparatus for performing catheter-based annuloplasty using local plications | |
JP4253582B2 (en) | Method and device for capturing and securing leaflets in valve therapy | |
US10327743B2 (en) | Device and methods for endoscopic annuloplasty | |
AU2006241065B2 (en) | Device and methods for endoscopic annuloplasty | |
CN117642137A (en) | Devices and methods for solving valve leaflet problems | |
WO2011034973A2 (en) | Methods, systems and devices for cardiac valve repair | |
JP2009519783A (en) | Papillary muscle position control device, system and method |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |